| 192 |
10.1001/jamaoncol.2018.0013 |
Safety And Efficacy Of Pembrolizumab Monotherapy In
Patients With Previously Treated Advanced Gastric And Gastroesophageal
Junction Cancer |
Fuchs, Charles S.; Doi, Toshihiko; Jang, Raymond W.;
Muro, Kei; Satoh, Taroh; Machado, Manuela; Sun, Weijing; Jalal, Shadia
I.; Shah, Manish A.; Metges, Jean-Phillipe; Garrido, Marcelo; Golan,
Talia; Mandala, Mario; Wainberg, Zev A.; Catenacci, Daniel V.; Ohtsu,
Atsushi; Shitara, Kohei; Geva, Ravit; Bleeker, Jonathan; Ko, Andrew H.;
Ku, Geoffrey; Philip, Philip; Enzinger, Peter C.; Bang, Yung-Jue;
Levitan, Diane; Wang, Jiangdian; Rosales, Minori; Dalal, Rita P.; Yoon,
Harry H. |
Jama Oncology |
2018 |
| 195 |
10.1001/jamaoncol.2018.2969 |
Assessment Of Resistance Mechanisms And Clinical
Implications In Patients Withegfrt790M<U+2013>Positive Lung Cancer
And Acquired Resistance To Osimertinib |
Oxnard, Geoffrey R.; Hu, Yuebi; Mileham, Kathryn F.;
Husain, Hatim; Costa, Daniel B.; Tracy, Philip; Feeney, Nora; Sholl,
Lynette M.; Dahlberg, Suzanne E.; Redig, Amanda J.; Kwiatkowski, David
J.; Rabin, Michael S.; Paweletz, Cloud P.; Thress, Kenneth S.; Janne,
Pasi A. |
Jama Oncology |
2018 |
| 198 |
10.1001/jamaoncol.2018.4224 |
Long-Term Clinical Outcomes And Biomarker Analyses Of
Atezolizumab Therapy For Patients With Metastatic Triple-Negative Breast
Cancer |
|
Jama Oncology |
2019 |
| 201 |
10.1001/jamaoncol.2018.5152 |
Atezolizumab Plus Nab-Paclitaxel In The Treatment Of
Metastatic Triple-Negative Breast Cancer With 2-Year Survival
Follow-Up |
Adams, Sylvia; Diamond, Jennifer R.; Hamilton, Erika;
Pohlmann, Paula R.; Tolaney, Sara M.; Chang, Ching-Wei; Zhang, Wei;
Iizuka, Koho; Foster, Paul G.; Molinero, Luciana; Funke, Roel; Powderly,
John |
Jama Oncology |
2019 |
| 203 |
10.1001/jamaoncol.2018.5441 |
Efficacy And Safety Of Pembrolizumab For Heavily
Pretreated Patients With Advanced, Metastatic Adenocarcinoma Or Squamous
Cell Carcinoma Of The Esophagus |
Shah, Manish A.; Kojima, Takashi; Hochhauser, Daniel;
Enzinger, Peter; Raimbourg, Judith; Hollebecque, Antoine; Lordick,
Florian; Kim, Sung-Bae; Tajika, Masahiro; Kim, Heung Tae; Lockhart, A.
Craig; Arkenau, Hendrik-Tobias; El-Hajbi, Farid; Gupta, Mukul; Pfeiffer,
Per; Liu, Qi; Lunceford, Jared; Kang, S. Peter; Bhagia, Pooja; Kato,
Ken |
Jama Oncology |
2019 |
| 207 |
10.1001/jamaoncol.2018.6258 |
Efficacy And Safety Of Avelumab For Patients With
Recurrent Or Refractory Ovarian Cancer |
Disis, Mary L.; Taylor, Matthew H.; Kelly, Karen; Beck,
J. Thaddeus; Gordon, Michael; Moore, Kathleen M.; Patel, Manish R.;
Chaves, Jorge; Park, Haeseong; Mita, Alain C.; Hamilton, Erika P.;
Annunziata, Christina M.; Grote, Hans Juergen; Von Heydebreck, Anja;
Grewal, Jaspreet; Chand, Vikram; Gulley, James L. |
Jama Oncology |
2019 |
| 213 |
10.1001/jamaoncol.2019.1029 |
Open-Label Clinical Trial Of Niraparib Combined With
Pembrolizumab For Treatment Of Advanced Or Metastatic Triple-Negative
Breast Cancer |
Vinayak, Shaveta; Tolaney, Sara M.; Schwartzberg, Lee;
Mita, Monica; Mccann, Georgia; Tan, Antoinette R.; Wahner-Hendrickson,
Andrea E.; Forero, Andres; Anders, Carey; Wulf, Gerburg M.; Dillon,
Patrick; Lynce, Filipa; Zarwan, Corrine; Erban, John K.; Zhou, Yinghui;
Buerstatte, Nathan; Graham, Julie R.; Arora, Sujata; Dezube, Bruce J.;
Telli, Melinda L. |
Jama Oncology |
2019 |
| 214 |
10.1001/jamaoncol.2019.1048 |
Single-Arm Phases 1 And 2 Trial Of Niraparib In
Combination With Pembrolizumab In Patients With Recurrent
Platinum-Resistant Ovarian Carcinoma |
|
Jama Oncology |
2019 |
| 217 |
10.1001/jamaoncol.2019.3343 |
Assessment Of Combined Nivolumab And Bevacizumab In
Relapsed Ovarian Cancer |
Liu, Joyce F.; Herold, Christina; Gray, Kathryn P.;
Penson, Richard T.; Horowitz, Neil; Konstantinopoulos, Panagiotis A.;
Castro, Cesar M.; Hill, Sarah J.; Curtis, Jennifer; Luo, Weixiu;
Matulonis, Ursula A.; Cannistra, Stephen A.; Dizon, Don S. |
Jama Oncology |
2019 |
| 220 |
10.1001/jamaoncol.2019.6650 |
Effect Of Pembrolizumab Plus Neoadjuvant Chemotherapy
On Pathologic Complete Response In Women With Early-Stage Breast
Cancer |
|
Jama Oncology |
2020 |
| 227 |
10.1001/jamaoncol.2020.3370 |
Efficacy And Safety Of Pembrolizumab Or Pembrolizumab
Plus Chemotherapy Vs Chemotherapy Alone For Patients With First-Line,
Advanced Gastric Cancer |
Shitara, Kohei; Van Cutsem, Eric; Bang, Yung-Jue;
Fuchs, Charles; Wyrwicz, Lucjan; Lee, Keun-Wook; Kudaba, Iveta; Garrido,
Marcelo; Chung, Hyun Cheol; Lee, Jeeyun; Castro, Hugo Raul; Mansoor,
Wasat; Braghiroli, Maria Ignez; Karaseva, Nina; Caglevic, Christian;
Villanueva, Luis; Goekkurt, Eray; Satake, Hironaga; Enzinger, Peter;
Alsina, Maria; Benson, Al; Chao, Joseph; Ko, Andrew H.; Wainberg, Zev
A.; Kher, Uma; Shah, Sukrut; Kang, S. Peter; Tabernero, Josep |
Jama Oncology |
2020 |
| 2002 |
10.1002/gcc.22671 |
A Novel Group Of Spindle Cell Tumors Defined By S100
And Cd34 Co-Expression Shows Recurrent Fusions Involving Raf1, Braf, And
Ntrk1/2 Genes |
Suurmeijer, Albert J. H.; Dickson, Brendan C.,
0000-0003-2269-6216; Swanson, David; Zhang, Lei; Sung, Yun-Shao; Cotzia,
Paolo; Fletcher, Christopher D. M.; Antonescu, Cristina R.,
0000-0002-9717-8205 |
Genes, Chromosomes And Cancer |
2018 |
| 2567 |
10.1007/s10120-018-00909-5 |
Pembrolizumab Alone Or In Combination With Chemotherapy
As First-Line Therapy For Patients With Advanced Gastric Or
Gastroesophageal Junction Adenocarcinoma: Results From The Phase Ii
Nonrandomized Keynote-059 Study |
Bang, Yung-Jue; Kang, Yoon-Koo; Catenacci, Daniel V.;
Muro, Kei; Fuchs, Charles S.; Geva, Ravit; Hara, Hiroki; Golan, Talia;
Garrido, Marcelo; Jalal, Shadia I.; Borg, Christophe; Doi, Toshihiko;
Yoon, Harry H.; Savage, Mary J.; Wang, Jiangdian; Dalal, Rita P.; Shah,
Sukrut; Wainberg, Zev A.; Chung, Hyun Cheol |
Gastric Cancer |
2019 |
| 3136 |
10.1016/j.annonc.2020.01.013 |
Tatton: A Multi-Arm, Phase Ib Trial Of Osimertinib
Combined With Selumetinib, Savolitinib, Or Durvalumab In Egfr-Mutant
Lung Cancer |
Oxnard, G.R.; Yang, J.C.-H.; Yu, H.; Kim, S.-W.; Saka,
H.; Horn, L.; Goto, K.; Ohe, Y.; Mann, H.; Thress, K.S.; Frigault, M.M.;
Vishwanathan, K.; Ghiorghiu, D.; Ramalingam, S.S.; Ahn, M.-J. |
Annals Of Oncology |
2020 |
| 3137 |
10.1016/j.annonc.2020.01.072 |
Pembrolizumab Plus Chemotherapy As Neoadjuvant
Treatment Of High-Risk, Early-Stage Triple-Negative Breast Cancer:
Results From The Phase 1B Open-Label, Multicohort Keynote-173 Study |
Schmid, P., 0000-0001-9817-5228; Salgado, R.; Park,
Y.H.; Munoz-Couselo, E.; Kim, S.B.; Sohn, J.; Im, S.-A.; Foukakis, T.;
Kuemmel, S.; Dent, R.; Yin, L.; Wang, A.; Tryfonidis, K.; Karantza, V.;
Cortes, J.; Loi, S. |
Annals Of Oncology |
2020 |
| 3143 |
10.1016/j.annonc.2020.04.478 |
Updated Overall Survival And Final Progression-Free
Survival Data For Patients With Treatment-Naive Advanced Alk-Positive
Non-Small-Cell Lung Cancer In The Alex Study |
Mok, T.; Camidge, D.R.; Gadgeel, S.M.; Rosell, R.;
Dziadziuszko, R.; Kim, D.-W.; Perol, M.; Ou, S.-H.I.; Ahn, J.S.; Shaw,
A.T.; Bordogna, W.; Smoljanovi<U+0107>, V.; Hilton, M.; Ruf, T.;
Noe, J.; Peters, S. |
Annals Of Oncology |
2020 |
| 3146 |
10.1016/j.annonc.2020.08.2102 |
Esmo Recommendations On Predictive Biomarker Testing
For Homologous Recombination Deficiency And Parp Inhibitor Benefit In
Ovarian Cancer |
Miller, R.E.; Leary, A.; Scott, C.L.; Serra, V.; Lord,
C.J.; Bowtell, D.; Chang, D.K.; Garsed, D.W.; Jonkers, J.; Ledermann,
J.A.; Nik-Zainal, S.; Ray-Coquard, I.; Shah, S.P.; Matias-Guiu, X.;
Swisher, E.M.; Yates, L.R. |
Annals Of Oncology |
2020 |
| 3148 |
10.1016/j.annonc.2020.08.2296 |
Lba6_Pr Nivolumab (Nivo) Plus Chemotherapy (Chemo)
Versus Chemo As First-Line (1L) Treatment For Advanced Gastric
Cancer/Gastroesophageal Junction Cancer (Gc/Gejc)/Esophageal
Adenocarcinoma (Eac): First Results Of The Checkmate 649 Study |
Moehler, M.; Shitara, K.; Garrido, M.; Salman, P.;
Shen, L.; Wyrwicz, L.; Yamaguchi, K.; Skoczylas, T.; Campos Bragagnoli,
A.; Liu, T.; Schenker, M.; Yanez, P.; Tehfe, M.; Poulart, V.; Cullen,
D.; Lei, M.; Kondo, K.; Li, M.; Ajani, J.A.; Janjigian, Y.Y. |
Annals Of Oncology |
2020 |
| 3149 |
10.1016/j.annonc.2020.08.2298 |
Lba8_Pr Pembrolizumab Plus Chemotherapy Versus
Chemotherapy As First-Line Therapy In Patients With Advanced Esophageal
Cancer: The Phase 3 Keynote-590 Study |
Kato, K.; Sun, J-M.; Shah, M.A.; Enzinger, P.C.;
Adenis, A.; Doi, T.; Kojima, T.; Metges, J-P.; Li, Z.; Kim, S-B.; Cho,
B.C. Chul; Mansoor, W.; Li, S-H.; Sunpaweravong, P.; Maqueda, M.A.;
Goekkurt, E.; Liu, Q.; Shah, S.; Bhagia, P.; Shen, L. |
Annals Of Oncology |
2020 |
| 3907 |
10.1016/j.ccell.2019.09.001 |
Pan-Cancer Landscape And Analysis Of Erbb2 Mutations
Identifies Poziotinib As A Clinically Active Inhibitor And Enhancer Of
T-Dm1 Activity |
Robichaux, Jacqulyne P.; Elamin, Yasir Y.; Vijayan,
R.S.K.; Nilsson, Monique B.; Hu, Lemei; He, Junqin; Zhang, Fahao;
Pisegna, Marlese; Poteete, Alissa; Sun, Huiying; Li, Shuai; Chen, Ting;
Han, Han; Negrao, Marcelo Vailati; Ahnert, Jordi Rodon; Diao, Lixia;
Wang, Jing; Le, Xiuning; Meric-Bernstam, Funda; Routbort, Mark; Roeck,
Brent; Yang, Zane; Raymond, Victoria M.; Lanman, Richard B.; Frampton,
Garrett M.; Miller, Vincent A.; Schrock, Alexa B.; Albacker, Lee A.;
Wong, Kwok-Kin; Cross, Jason B.; Heymach, John V. |
Cancer Cell |
2019 |
| 4462 |
10.1016/j.celrep.2018.11.054 |
Parp Inhibition Elicits Sting-Dependent Antitumor
Immunity In Brca1-Deficient Ovarian Cancer |
Ding, Liya; Kim, Hye-Jung; Wang, Qiwei; Kearns,
Michael; Jiang, Tao; Ohlson, Carolynn E.; Li, Ben B.; Xie, Shaozhen;
Liu, Joyce F.; Stover, Elizabeth H.; Howitt, Brooke E.; Bronson,
Roderick T.; Lazo, Suzan; Roberts, Thomas M.; Freeman, Gordon J.;
Konstantinopoulos, Panagiotis A.; Matulonis, Ursula A.; Zhao, Jean
J. |
Cell Reports |
2018 |
| 5382 |
10.1016/j.ebiom.2019.01.019 |
Prediction Of Alk Mutations Mediating Alk-Tkis
Resistance And Drug Re-Purposing To Overcome The Resistance |
Okada, Koutaroh; Araki, Mitsugu; Sakashita, Takuya; Ma,
Biao; Kanada, Ryo; Yanagitani, Noriko; Horiike, Atsushi; Koike, Sumie;
Oh-Hara, Tomoko; Watanabe, Kana; Tamai, Keiichi; Maemondo, Makoto;
Nishio, Makoto; Ishikawa, Takeshi, 0000-0002-3187-1381; Okuno, Yasushi;
Fujita, Naoya; Katayama, Ryohei, 0000-0001-7394-895X |
Ebiomedicine |
2019 |
| 7592 |
10.1016/j.jmoldx.2019.03.008 |
Detection Of Tumor Ntrk Gene Fusions To Identify
Patients Who May Benefit From Tyrosine Kinase (Trk) Inhibitor
Therapy |
Hsiao, Susan J., 0000-0002-0319-4969; Zehir, Ahmet,
0000-0001-5406-4104; Sireci, Anthony N.; Aisner, Dara L. |
The Journal Of Molecular Diagnostics |
2019 |
| 7887 |
10.1016/j.jtho.2019.02.001 |
Osimertinib Plus Durvalumab Versus Osimertinib
Monotherapy In Egfr T790M<U+2013>Positive Nsclc Following Previous
Egfr Tki Therapy: Caural Brief Report |
Yang, James Chih-Hsin; Shepherd, Frances A.; Kim,
Dong-Wan; Lee, Gyeong-Won; Lee, Jong Seok; Chang, Gee-Chen; Lee, Sung
Sook; Wei, Yu-Feng; Lee, Yun Gyoo; Laus, Gianluca; Collins, Barbara;
Pisetzky, Francesca; Horn, Leora |
Journal Of Thoracic Oncology |
2019 |
| 7888 |
10.1016/j.jtho.2019.03.007 |
Updated Efficacy And Safety Data And Impact Of The
Eml4-Alk Fusion Variant On The Efficacy Of Alectinib In Untreated
Alk-Positive Advanced Non<U+2013>Small Cell Lung Cancer In The
Global Phase Iii Alex Study |
Camidge, D. Ross; Dziadziuszko, Rafal; Peters, Solange;
Mok, Tony; Noe, Johannes; Nowicka, Malgorzata; Gadgeel, Shirish M.;
Cheema, Parneet; Pavlakis, Nick; De Marinis, Filippo; Cho, Byoung Chul;
Zhang, Li; Moro-Sibilot, Denis; Liu, Ting; Bordogna, Walter; Balas,
Bogdana; Muller, Barbara; Shaw, Alice T. |
Journal Of Thoracic Oncology |
2019 |
| 7889 |
10.1016/j.jtho.2019.04.026 |
Durvalumab In Combination With Olaparib In Patients
With Relapsed Sclc: Results From A Phase Ii Study |
Thomas, Anish; Vilimas, Rasa; Trindade, Christopher;
Erwin-Cohen, Rebecca; Roper, Nitin; Xi, Liqiang; Krishnasamy, Venkatesh;
Levy, Elliot; Mammen, Andy; Nichols, Samantha; Chen, Yuanbin; Velcheti,
Vamsidhar; Yin, Faye; Szabo, Eva; Pommier, Yves; Steinberg, Seth M.;
Trepel, Jane B.; Raffeld, Mark; Young, Howard A.; Khan, Javed; Hewitt,
Stephen; Lee, Jung-Min |
Journal Of Thoracic Oncology |
2019 |
| 7890 |
10.1016/j.jtho.2019.06.002 |
Concurrent Rb1 And Tp53 Alterations Define A Subset Of
Egfr-Mutant Lung Cancers At Risk For Histologic Transformation And
Inferior Clinical Outcomes |
|
Journal Of Thoracic Oncology |
2019 |
| 7896 |
10.1016/j.jtho.2019.12.129 |
Efficacy And Safety Of Anti<U+2013>Pd-1
Immunotherapy In Patients With Advanced Nsclc With Braf, Her2, Or Met
Mutations Or Ret Translocation: Gfpc 01-2018 |
Guisier, Florian, 0000-0002-8166-7303; Dubos-Arvis,
Catherine; Vinas, Florent; Doubre, Helene; Ricordel, Charles; Ropert,
Stanislas; Janicot, Henri; Bernardi, Marie; Fournel, Pierre; Lamy,
Regine; Perol, Maurice; Dauba, Jerome; Gonzales, Gilles; Falchero,
Lionel; Decroisette, Chantal; Assouline, Pascal; Chouaid, Christos;
Bylicki, Olivier |
Journal Of Thoracic Oncology |
2020 |
| 7897 |
10.1016/j.jtho.2020.01.006 |
Ret Solvent Front Mutations Mediate Acquired Resistance
To Selective Ret Inhibition In Ret-Driven Malignancies |
Solomon, Benjamin J.; Tan, Lavinia; Lin, Jessica J.;
Wong, Stephen Q.; Hollizeck, Sebastian; Ebata, Kevin; Tuch, Brian B.;
Yoda, Satoshi; Gainor, Justin F.; Sequist, Lecia V.; Oxnard, Geoffrey
R.; Gautschi, Oliver; Drilon, Alexander; Subbiah, Vivek; Khoo,
Christine; Zhu, Edward Y.; Nguyen, Michele; Henry, Dahlia; Condroski,
Kevin R.; Kolakowski, Gabrielle R.; Gomez, Eliana; Ballard, Joshua;
Metcalf, Andrew T.; Blake, James F.; Dawson, Sarah-Jane; Blosser, Wayne;
Stancato, Louis F.; Brandhuber, Barbara J.; Andrews, Steve; Robinson,
Bruce G.; Rothenberg, S. Michael |
Journal Of Thoracic Oncology |
2020 |
| 10054 |
10.1016/j.ygyno.2018.11.017 |
Pembrolizumab In Patients With Programmed Death Ligand
1<U+2013>Positive Advanced Ovarian Cancer: Analysis Of
Keynote-028 |
Varga, Andrea; Piha-Paul, Sarina; Ott, Patrick A.;
Mehnert, Janice M.; Berton-Rigaud, Dominique; Morosky, Anne; Yang, Ping;
Ruman, Jane; Matei, Daniela |
Gynecologic Oncology |
2019 |
| 10086 |
10.1016/s0140-6736(18)31257-1 |
Pembrolizumab Versus Paclitaxel For Previously Treated,
Advanced Gastric Or Gastro-Oesophageal Junction Cancer (Keynote-061): A
Randomised, Open-Label, Controlled, Phase 3 Trial |
Shitara, Kohei; Ozguro<U+011F>lu, Mustafa; Bang,
Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro,
Lorenzo; Olesi<U+0144>ski, Tomasz; Caglevic, Christian; Chung,
Hyun C; Muro, Kei; Goekkurt, Eray; Mansoor, Wasat; Mcdermott, Raymond S;
Shacham-Shmueli, Einat; Chen, Xinqun; Mayo, Carlos; Kang, S Peter;
Ohtsu, Atsushi; Fuchs, Charles S; Lerzo, Guillermo; O’Connor, Juan
Manuel; Mendez, Guillermo Ariel; Lynam, James; Tebbutt, Niall; Wong,
Mark; Strickland, Andrew; Karapetis, Chris; Goldstein, David; Vasey,
Paul; Van Laethem, Jean-Luc; Van Cutsem, Eric; Berry, Scott; Vincent,
Mark; Muller, Bettina; Rey, Felipe; Zambrano, Angela; Guerra, Joaquin;
Krogh, Merete; Baeksgaard, Lene; Yilmaz, Mette; Elme, Anneli; Magi,
Andrus; Auvinen, Paivi; Alanko, Tuomo; Moehler, Markus; Kunzmann,
Volker; Seufferlein, Thomas; Thuss-Patience, Peter; Goekkurt, Eray;
Hoehler, Thomas; Haag, Georg; Al-Batran, Salah-Eddin; Castro, Hugo;
Lopez, Karla; Aguilar Vasquez, Mynor; Sandoval, Mario; Lam, Ka On;
Cuffe, Sinead; Kelly, Cathy; Geva, Ravit; Shacham-Shmueli, Einat;
Hubert, Ayala; Beny, Alex; Brenner, Baruch; Giuseppe, Aprile; Falcone,
Alfredo; Maiello, Evaristo; Passalacqua, Rodolfo; Montesarchio,
Vincenzo; Hara, Hiroki; Chin, Keisho; Nishina, Tomohiro; Komatsu,
Yoshito; Machida, Nozumo; Hironaka, Shuichi; Satoh, Taroh; Tamura,
Takao; Sugimoto, Naotaoshi; Cho, Haruhiko; Omuro, Yashushi; Kato, Ken;
Goto, Masahiro; Hyodo, Ichinosuke; Yoshida, Kazuhiro; Baba, Hideo;
Esaki, Taito; Furuse, Junji; Wan Mohammed, Wan Zamaniah; Hernandez
Hernandez, Carlos; Casas Garcia, Juan; Dominguez Andrade, Adriana;
Clarke, Katriona; Hjortland, Geir; Glenjen, Nils; Kubiatowski, Tomasz;
Jacek, Jassem; Wojtukiewicz, Marek; Lazarev, Sergey; Lancukhay, Yuri;
Afanasayev, Sergey; Moiseyenko, Vladimir; Kostorov, Vladimir; Protsenko,
Svetlana; Shirinkin, Vadim; Sakaeva, Dina; Fadeeva, Natalia; Yong, Wei
Peng; Ng, Chau Hsien Matthew; Robertson, Barbara; Rapaport, Bernardo;
Cohen, Graham; Dreosti, Lydia; Ruff, Paul; Jacobs, Conrad; Landers,
Gregory; Szpak, Waldemar; Roh, Sang-Young; Lee, Jeeyun; Kim, Yeul Hong;
Bang, Yung-Jue; Chung, Hyun Cheol; Ryu, Min-Hee; Alsina Maqueda, Maria;
Longo Munoz, Federico; Cervantes Aguilar, Andres; Aranda Aguilar,
Enrique; Garcia Alfonso, Pilar; Rivera, Fernando; Feliu Batle, Jaime;
Pazo Cid, Roberto; Yeh, Kun-Huei; Chen, Jen-Shi; Chao, Yee; Yen,
Chia-Jui; Ozguro<U+011F>lu, Mustafa; Kara, Oguz; Yalcin, Suayib;
Hochhauser, Daniel; Chau, Ian; Benson, Al; Shankaran, Veena; Shaib,
Walid; Philip, Philip; Sharma, Vivek; Siegel, Robert; Sun, Weijing;
Wainberg, Zev; George, Ben; Bullock, Andrea; Myrick, Samuel; Faruol,
Josephine; Siegel, Richard; Larson, Timothy; Becerra, Carlos; Ratnam,
Suresh; Richards, Donald A.; Riche, Stephen L. |
The Lancet |
2018 |
| 10116 |
10.1016/s0140-6736(19)30650-6 |
6 Versus 12 Months Of Adjuvant Trastuzumab For
Her2-Positive Early Breast Cancer (Persephone): 4-Year Disease-Free
Survival Results Of A Randomised Phase 3 Non-Inferiority Trial |
Earl, Helena M; Hiller, Louise; Vallier, Anne-Laure;
Loi, Shrushma; Mcadam, Karen; Hughes-Davies, Luke; Harnett, Adrian N;
Ah-See, Mei-Lin; Simcock, Richard; Rea, Daniel; Raj, Sanjay; Woodings,
Pamela; Harries, Mark; Howe, Donna; Raynes, Kerry; Higgins, Helen B;
Wilcox, Maggie; Plummer, Chris; Mansi, Janine; Gounaris, Ioannis;
Mahler<U+2013>Araujo, Betania; Provenzano, Elena; Chhabra, Anita;
Abraham, Jean E; Caldas, Carlos; Hall, Peter S; Mccabe, Christopher;
Hulme, Claire; Miles, David; Wardley, Andrew M; Cameron, David A; Dunn,
Janet A; Agarwal, Roshan; Algurafi, Hafiz; Allerton, Rozenn; Archer,
Caroline; Armstrong, Anne; Bale, Catherine; Barraclough, Lisa;
Barthakur, Urmila; Bedi, Carolyn; Benstead, Kim; Bloomfield, David;
Bowen, Rebecca; Bradley, Chris; Brown, Jane; Butt, Mohammad; Churn,
Mark; Cleator, Susan; Cliff, Joanne; Crellin, Perric; Daly, Margaret; De
Silva-Minor, Shiroma; Dhadda, Amandeep; Din, Omar; Down, Sue; Earl,
Helena; Eaton, David; Eichholz, Andrew; Epurescu, Daniel; Goh, Chee;
Goodman, Andrew; Grieve, Robert; Hadaki, Maher; Harper-Wynne, Catherine;
Harries, Mark; Hayward, Larry; Humphreys, Alison; Innes, Helen; Jafri,
Mariam; Jegannathen, Apurna; Kelleher, Muireann; Kristeleit, Hartmut;
Lee, Daniela; Lupton, Susan; Macgregor, Carol; Malik, Zafar; Mansi,
Janine; Marshall, Jennifer; Mcadam, Karen; Mcgolick, Trevor; Mehra,
Rakesh; Miles, David; Mithal, Natasha; Moss, Charlotte; Moss, Aian;
Mukesh, Mukesh; Neal, Anthony; Nelmes, Daniel; Neville-Webbe, Helen;
Newby, Jacqueline; O’Reilly, Susan; Ostler, Peter; Persic, Mojca;
Pettit, Laura; Raj, Sanjay; Raja, Fharat; Rea, Daniel; Reed, Catherine;
Rigg, Anne; Roe, Helen; Shah, Nihal; Simmonds, Peter; Sims, Eliot;
Smith, Sarah; Storey, Nicola; Taylor, Wendy; Thanvi, Narottam; Tipples,
Karen; Vaidya, Jayant; Varughese, Mohini; Vinayan, Anup; Walji, Nawaz;
Waters, Simon; Woodings, Pamela; Wright, Kathryn; Yahya, Sundus |
The Lancet |
2019 |
| 10135 |
10.1016/s0140-6736(19)32259-7 |
Weekly Dose-Dense Chemotherapy In First-Line Epithelial
Ovarian, Fallopian Tube, Or Primary Peritoneal Carcinoma Treatment
(Icon8): Primary Progression Free Survival Analysis Results From A Gcig
Phase 3 Randomised Controlled Trial |
Clamp, Andrew R; James, Elizabeth C; Mcneish, Iain A;
Dean, Andrew; Kim, Jae-Weon; O’Donnell, Dearbhaile M; Hook, Jane; Coyle,
Christopher; Blagden, Sarah; Brenton, James D; Naik, Raj; Perren, Tim;
Sundar, Sudha; Cook, Adrian D; Gopalakrishnan, Gosala S; Gabra, Hani;
Lord, Rosemary; Dark, Graham; Earl, Helena M; Hall, Marcia; Banerjee,
Susana; Glasspool, Rosalind M; Jones, Rachel; Williams, Sarah; Swart,
Ann Marie; Stenning, Sally; Parmar, Mahesh; Kaplan, Richard; Ledermann,
Jonathan A |
The Lancet |
2019 |
| 10214 |
10.1016/s0140-6736(20)31953-x |
Neoadjuvant Atezolizumab In Combination With Sequential
Nab-Paclitaxel And Anthracycline-Based Chemotherapy Versus Placebo And
Chemotherapy In Patients With Early-Stage Triple-Negative Breast Cancer
(Impassion031): A Randomised, Double-Blind, Phase 3 Trial |
Mittendorf, Elizabeth A; Zhang, Hong; Barrios, Carlos
H; Saji, Shigehira; Jung, Kyung Hae; Hegg, Roberto; Koehler, Andreas;
Sohn, Joohyuk; Iwata, Hiroji; Telli, Melinda L; Ferrario, Cristiano;
Punie, Kevin; Penault-Llorca, Frederique; Patel, Shilpen; Duc, Anh
Nguyen; Liste-Hermoso, Mario; Maiya, Vidya; Molinero, Luciana; Chui,
Stephen Y; Harbeck, Nadia |
The Lancet |
2020 |
| 10221 |
10.1016/s0140-6736(20)32531-9 |
Pembrolizumab Plus Chemotherapy Versus Placebo Plus
Chemotherapy For Previously Untreated Locally Recurrent Inoperable Or
Metastatic Triple-Negative Breast Cancer (Keynote-355): A Randomised,
Placebo-Controlled, Double-Blind, Phase 3 Clinical Trial |
Cortes, Javier; Cescon, David W; Rugo, Hope S; Nowecki,
Zbigniew; Im, Seock-Ah; Yusof, Mastura Md; Gallardo, Carlos; Lipatov,
Oleg; Barrios, Carlos H; Holgado, Esther; Iwata, Hiroji; Masuda,
Norikazu; Otero, Marco Torregroza; Gokmen, Erhan; Loi, Sherene; Guo,
Zifang; Zhao, Jing; Aktan, Gursel; Karantza, Vassiliki; Schmid, Peter;
Luis, Fein; Gonzalo, Gomez Abuin; Diego, Kaen; Ruben, Kowalwszyn;
Matias, Molina; Mirta, Varela; Sally, Baron-Hay; Stephen, Begbie;
Philip, Clingan; Sherene, Loi; Dhanusha, Sabanathan; Andrea, Gombos;
Donatienne, Taylor; Carlos, Barrios; Leandro, Brust; Fabiano, Costa;
Ruffo, De Freitas Junior; Roberto, Hegg; Domicio Carvalho, Lacerda;
Fernando Cezar Toniazzi, Lissa; Roberto Odebrecht, Rocha; Antonio
Orlando, Scalabrini Neto; Felipe, Silva; David, Cescon; Danielle,
Charpentier; Cristiano, Ferrario; Xinni, Song; Joanne, Yu; Alejandro,
Acevedo; Carlos, Gallardo; Claudio, Salas; Cesar, Sanchez; Eduardo,
Yanez; Alvaro, Gomez Diaz; Jesus, Sanchez; Petra, Holeckova; Zdenek,
Kral; Bohuslav, Melichar; Katarina, Petrakova; Jana, Prausova; Vesna,
Glavicic; Erik, Jakobsen; Jeanette, Jensen; Soren, Linnet; Tamas,
Lorincz; Herve, Bonnefoi; Isabelle, Desmoulins; Anthony, Goncalves;
Anne-Claire, Hardy-Bessard; Luis, Teixeira; Jens-Uwe, Blohmer; Peter,
Fasching; Dirk, Forstmeyer; Nadia, Harbeck; Jens, Huober; Anna,
Kaczerowsky Flores De Sousa; Christian, Kurbacher; Sibylle, Loibl;
Diana, Lueftner; Tjoung-Won, Park-Simon; Raquel Von, Schumann; Pauline,
Wimberger; Louis, Chow; Ava, Kwong; Kai Cheong Roger, Ngan; Peter,
Arkosy; Tibor, Csoszi; Zsuzsanna, Kahan; Laszlo, Landherr; Karoly, Mahr;
Gabor, Rubovszky; John, Crown; Catherine, Kelly; Seamus, O’Reilly;
Saverio, Cinieri; Antonietta, Dalessio; Enrico, Ricevuto; Tomoyuki,
Aruga; Takaaki, Fujii; Kenichi, Inoue; Takashi, Ishikawa; Yoshinori,
Ito; Tsutomu, Iwasa; Hiroji, Iwata; Yoshimasa, Kosaka; Koji, Matsumoto;
Yasuo, Miyoshi; Hirofumi, Mukai; Seigo, Nakamura; Naoki, Niikura;
Shoichiro, Ohtani; Akihiko, Osaki; Yasuaki, Sagara; Eiji, Suzuki;
Masato, Takahashi; Yuko, Tanabe; Kenji, Tamura; Koichiro, Tsugawa;
Junichiro, Watanabe; Naohito, Yamamoto; Yutaka, Yamamoto; Teruo,
Yamauchi; Anita, Bustam; Mastura, Md Yusof; Angel, Gomez Villanueva;
Alejandro, Juarez Ramiro; Jorge, Martinez Rodriguez; Flavia,
Morales-Vasquez; Jessica, Reyes Contreras; Karin, Beelen; Vivianne,
Tjan-Heijnen; David, Porter; Ewa, Chmielowska; Ewa, Nowakowska-Zajdel;
Zbigniew, Nowecki; Barbara, Radecka; Joanna, Streb; Cezary, Szczylik;
Rafal, Tarnawski; Bogdan, Zurawski; Alexander, Arkhipov; Natalia,
Fadeeva; Oleg, Lipatov; Andrey, Meshcheryakov; Vladimir, Moiseyenko;
Guzel, Mukhametshina; Jin Hee, Ahn; Seock-Ah, Im; Keun Seok, Lee; Kwong
Hwa, Park; Yeon Hee, Park; Begona, Bermejo De Las Heras; Javier, Cortes;
Josefina, Cruz Jurado; Luis, De La Cruz Merino; Jose, Garcia Saenz;
Maria, Gion; Esther, Holgado; Esther, Zamora Adelantado; Chien-Ting,
Liu; Mei-Ching, Liu; Chiun-Sheng, Huang; Chao-Jung, Tsao; Ling-Ming,
Tseng; Cagatay, Arslan; Gul, Basaran; Irfan, Cicin; Erhan, Gokmen;
Seyda, Gunduz; Nil, Molinas Mandel; Mustafa, Ozguroglu; Ozgur, Ozyilkan;
Sinan, Yavuz; Steve, Chan; Janine, Graham; Iain, Macpherson; Peter,
Schmid; Nicholas, Turner; Mark, Tuthill; Christopher, Twelves; Duncan,
Wheatley; Hryhoriy, Adamchuk; Oleksandr, Berzoy; Igor, Bondarenko;
Oleksii, Kolesnik; Olena, Kolesnik; Hanna, Komisarenko; Anna,
Kryzhanivska; Iurii, Leshchenko; Alla, Nasonova; Natalya, Otchenash;
Olga, Ponomarova; Andrii, Rusyn; Sergii, Shevnya; Yaroslav, Shparyk;
Dmytro, Trukhin; Grygorii, Ursol; Ihor, Vynnychenko; Sibel, Blau; Madhu,
Chaudhry; Michael, Chung; Patrick, Cobb; Scott, Cole; Jennifer, Diamond;
Keerthi, Gogineni; Jeffrey, Hargis; Kent, Hoskins; William, Irvin;
Randa, Loutfi; Janice, Lu; Raul, Mena; Susan, Moore; Rita, Nanda; Ira,
Oliff; Coral, Omene; Timothy, Panella; Amit, Panwalkar; Brian, Patson;
Hope, Rugo; Irina, Rybalova; Michael, Schleider; Robert, Siegel;
Michael, Simon; Laura, Stampleman; Bradley, Sumrall; Michaela, Tsai;
Frances, Valdes-Albini |
The Lancet |
2020 |
| 10240 |
10.1016/s0140-6736(21)00797-2 |
First-Line Nivolumab Plus Chemotherapy Versus
Chemotherapy Alone For Advanced Gastric, Gastro-Oesophageal Junction,
And Oesophageal Adenocarcinoma (Checkmate 649): A Randomised,
Open-Label, Phase 3 Trial |
Janjigian, Yelena Y; Shitara, Kohei; Moehler, Markus;
Garrido, Marcelo; Salman, Pamela; Shen, Lin; Wyrwicz, Lucjan; Yamaguchi,
Kensei; Skoczylas, Tomasz; Campos Bragagnoli, Arinilda; Liu, Tianshu;
Schenker, Michael; Yanez, Patricio; Tehfe, Mustapha; Kowalyszyn, Ruben;
Karamouzis, Michalis V; Bruges, Ricardo; Zander, Thomas; Pazo-Cid,
Roberto; Hitre, Erika; Feeney, Kynan; Cleary, James M; Poulart, Valerie;
Cullen, Dana; Lei, Ming; Xiao, Hong; Kondo, Kaoru; Li, Mingshun; Ajani,
Jaffer A |
The Lancet |
2021 |
| 10248 |
10.1016/s1470-2045(18)30111-6 |
Addition Of The Parp Inhibitor Veliparib Plus
Carboplatin Or Carboplatin Alone To Standard Neoadjuvant Chemotherapy In
Triple-Negative Breast Cancer (Brightness): A Randomised, Phase 3
Trial |
Loibl, Sibylle; O’Shaughnessy, Joyce; Untch, Michael;
Sikov, William M; Rugo, Hope S; Mckee, Mark D; Huober, Jens; Golshan,
Mehra; Von Minckwitz, Gunter; Maag, David; Sullivan, Danielle; Wolmark,
Norman; Mcintyre, Kristi; Ponce Lorenzo, Jose J; Metzger Filho, Otto;
Rastogi, Priya; Symmans, W Fraser; Liu, Xuan; Geyer, Charles E |
The Lancet Oncology |
2018 |
| 10249 |
10.1016/s1470-2045(18)30119-0 |
Larotrectinib For Paediatric Solid Tumours Harbouring
Ntrk Gene Fusions: Phase 1 Results From A Multicentre, Open-Label, Phase
1/2 Study |
Laetsch, Theodore W; Dubois, Steven G; Mascarenhas,
Leo; Turpin, Brian; Federman, Noah; Albert, Catherine M;
Nagasubramanian, Ramamoorthy; Davis, Jessica L; Rudzinski, Erin; Feraco,
Angela M; Tuch, Brian B; Ebata, Kevin T; Reynolds, Mark; Smith, Steven;
Cruickshank, Scott; Cox, Michael C; Pappo, Alberto S; Hawkins, Douglas
S |
The Lancet Oncology |
2018 |
| 10259 |
10.1016/s1470-2045(18)30481-9 |
Pertuzumab Plus Trastuzumab And Chemotherapy For
Her2-Positive Metastatic Gastric Or Gastro-Oesophageal Junction Cancer
(Jacob): Final Analysis Of A Double-Blind, Randomised,
Placebo-Controlled Phase 3 Study |
Tabernero, Josep; Hoff, Paulo M; Shen, Lin; Ohtsu,
Atsushi; Shah, Manish A; Cheng, Karen; Song, Chunyan; Wu, Haiyan;
Eng-Wong, Jennifer; Kim, Katherine; Kang, Yoon-Koo |
The Lancet Oncology |
2018 |
| 10262 |
10.1016/s1470-2045(18)30570-9 |
Neoadjuvant Chemotherapy With Or Without Anthracyclines
In The Presence Of Dual Her2 Blockade For Her2-Positive Breast Cancer
(Train-2): A Multicentre, Open-Label, Randomised, Phase 3 Trial |
Van Ramshorst, Mette S; Van Der Voort, Anna; Van
Werkhoven, Erik D; Mandjes, Ingrid A; Kemper, Inge; Dezentje, Vincent O;
Oving, Irma M; Honkoop, Aafke H; Tick, Lidwine W; Van De Wouw, Agnes J;
Mandigers, Caroline M; Van Warmerdam, Laurence J; Wesseling, Jelle;
Vrancken Peeters, Marie-Jeanne T; Linn, Sabine C; Sonke, Gabe S |
The Lancet Oncology |
2018 |
| 10267 |
10.1016/s1470-2045(18)30649-1 |
Lorlatinib In Patients With Alk-Positive Non-Small-Cell
Lung Cancer: Results From A Global Phase 2 Study |
Solomon, Benjamin J; Besse, Benjamin; Bauer, Todd M;
Felip, Enriqueta; Soo, Ross A; Camidge, D Ross; Chiari, Rita; Bearz,
Alessandra; Lin, Chia-Chi; Gadgeel, Shirish M; Riely, Gregory J; Tan,
Eng Huat; Seto, Takashi; James, Leonard P; Clancy, Jill S; Abbattista,
Antonello; Martini, Jean-Francois; Chen, Joseph; Peltz, Gerson; Thurm,
Holger; Ou, Sai-Hong Ignatius; Shaw, Alice T |
The Lancet Oncology |
2018 |
| 10270 |
10.1016/s1470-2045(18)30739-3 |
Trifluridine/Tipiracil Versus Placebo In Patients With
Heavily Pretreated Metastatic Gastric Cancer (Tags): A Randomised,
Double-Blind, Placebo-Controlled, Phase 3 Trial |
Shitara, Kohei; Doi, Toshihiko; Dvorkin, Mikhail;
Mansoor, Wasat; Arkenau, Hendrik-Tobias; Prokharau, Aliaksandr; Alsina,
Maria; Ghidini, Michele; Faustino, Catia; Gorbunova, Vera; Zhavrid,
Edvard; Nishikawa, Kazuhiro; Hosokawa, Ayumu; Yalc<U+0131>n,
<U+015E>uayib; Fujitani, Kazumasa; Beretta, Giordano D; Cutsem,
Eric Van; Winkler, Robert E; Makris, Lukas; Ilson, David H; Tabernero,
Josep |
The Lancet Oncology |
2018 |
| 10274 |
10.1016/s1470-2045(18)30812-x |
Pembrolizumab Plus Trastuzumab In
Trastuzumab-Resistant, Advanced, Her2-Positive Breast Cancer (Panacea):
A Single-Arm, Multicentre, Phase 1B<U+2013>2 Trial |
Loi, Sherene; Giobbie-Hurder, Anita; Gombos, Andrea;
Bachelot, Thomas; Hui, Rina; Curigliano, Giuseppe; Campone, Mario;
Biganzoli, Laura; Bonnefoi, Herve; Jerusalem, Guy; Bartsch, Rupert;
Rabaglio-Poretti, Manuela; Kammler, Roswitha; Maibach, Rudolf; Smyth,
Mark J; Di Leo, Angelo; Colleoni, Marco; Viale, Giuseppe; Regan,
Meredith M; Andre, Fabrice; Fumagalli, Debora; Gelber, Richard D;
Goulioti, Theodora; Hiltbrunner, Anita; Hui, Rita; Roschitzki, Heidi;
Ruepp, Barbara; Boyle, Fran; Stahel, Rolf; Aebi, Stefan; Coates, Alan S;
Goldhirsch, Aron; Karlsson, Per; Kossler, Ingrid; Fournarakou,
Stamatina; Gasca, Adriana; Pfister, Rita; Ribeli-Hofmann, Sabrina;
Weber, Magdelena; Celotto, Daniela; Comune, Carmen; Frapolli, Michela;
Sanchez-Hohl, Magdalena; Huang, Hui; Mahoney, Caitlin; Price, Karen;
Scott, Karolyn; Shaw, Holly; Fischer, Susan; Greco, Monica; King,
Colleen; Andrighetto, Stefania; Piccart-Gebhart, Martine; Findlay,
Heather; Jenkins, Michelle; Karantza, Vassiliki; Mejia, Jaime; Schneier,
Patrick |
The Lancet Oncology |
2019 |
| 10276 |
10.1016/s1470-2045(18)30905-7 |
|
Konstantinopoulos, Panagiotis A; Barry, William T;
Birrer, Michael; Westin, Shannon N; Cadoo, Karen A; Shapiro, Geoffrey I;
Mayer, Erica L; O’Cearbhaill, Roisin E; Coleman, Robert L;
Kochupurakkal, Bose; Whalen, Christin; Curtis, Jennifer; Farooq, Sarah;
Luo, Weixiu; Eismann, Julia; Buss, Mary K; Aghajanian, Carol; Mills,
Gordon B; Palakurthi, Sangeetha; Kirschmeier, Paul; Liu, Joyce; Cantley,
Lewis C; Kaufmann, Scott H; Swisher, Elizabeth M; D’Andrea, Alan D;
Winer, Eric; Wulf, Gerburg M; Matulonis, Ursula A |
The Lancet Oncology |
2019 |
| 10280 |
10.1016/s1470-2045(19)30029-4 |
Niraparib Monotherapy For Late-Line Treatment Of
Ovarian Cancer (Quadra): A Multicentre, Open-Label, Single-Arm, Phase 2
Trial |
Moore, Kathleen N; Secord, Angeles Alvarez; Geller,
Melissa A; Miller, David Scott; Cloven, Noelle; Fleming, Gini F; Wahner
Hendrickson, Andrea E; Azodi, Masoud; Disilvestro, Paul; Oza, Amit M;
Cristea, Mihaela; Berek, Jonathan S; Chan, John K; Rimel, Bobbie J;
Matei, Daniela E; Li, Yong; Sun, Kaiming; Luptakova, Katarina;
Matulonis, Ursula A; Monk, Bradley J |
The Lancet Oncology |
2019 |
| 10281 |
10.1016/s1470-2045(19)30035-x |
Erlotinib Plus Bevacizumab Versus Erlotinib Alone In
Patients With Egfr-Positive Advanced Non-Squamous Non-Small-Cell Lung
Cancer (Nej026): Interim Analysis Of An Open-Label, Randomised,
Multicentre, Phase 3 Trial |
Saito, Haruhiro; Fukuhara, Tatsuro; Furuya, Naoki;
Watanabe, Kana; Sugawara, Shunichi; Iwasawa, Shunichiro; Tsunezuka,
Yoshio; Yamaguchi, Ou; Okada, Morihito; Yoshimori, Kozo; Nakachi,
Ichiro; Gemma, Akihiko; Azuma, Koichi; Kurimoto, Futoshi; Tsubata,
Yukari; Fujita, Yuka; Nagashima, Hiromi; Asai, Gyo; Watanabe, Satoshi;
Miyazaki, Masaki; Hagiwara, Koichi; Nukiwa, Toshihiro; Morita, Satoshi;
Kobayashi, Kunihiko; Maemondo, Makoto |
The Lancet Oncology |
2019 |
| 10283 |
10.1016/s1470-2045(19)30088-9 |
Trastuzumab Deruxtecan (Ds-8201A) In Patients With
Advanced Her2-Positive Gastric Cancer: A Dose-Expansion, Phase 1
Study |
Shitara, Kohei; Iwata, Hiroji; Takahashi, Shunji;
Tamura, Kenji; Park, Haeseong; Modi, Shanu; Tsurutani, Junji; Kadowaki,
Shigenori; Yamaguchi, Kensei; Iwasa, Satoru; Saito, Kaku; Fujisaki,
Yoshihiko; Sugihara, Masahiro; Shahidi, Javad; Doi, Toshihiko |
The Lancet Oncology |
2019 |
| 10285 |
10.1016/s1470-2045(19)30097-x |
Trastuzumab Deruxtecan (Ds-8201A) In Patients With
Advanced Her2-Positive Breast Cancer Previously Treated With Trastuzumab
Emtansine: A Dose-Expansion, Phase 1 Study |
Tamura, Kenji; Tsurutani, Junji; Takahashi, Shunji;
Iwata, Hiroji; Krop, Ian E; Redfern, Charles; Sagara, Yasuaki; Doi,
Toshihiko; Park, Haeseong; Murthy, Rashmi K; Redman, Rebecca A; Jikoh,
Takahiro; Lee, Caleb; Sugihara, Masahiro; Shahidi, Javad; Yver, Antoine;
Modi, Shanu |
The Lancet Oncology |
2019 |
| 10291 |
10.1016/s1470-2045(19)30328-6 |
Trastuzumab Duocarmazine In Locally Advanced And
Metastatic Solid Tumours And Her2-Expressing Breast Cancer: A Phase 1
Dose-Escalation And Dose-Expansion Study |
Banerji, Udai; Van Herpen, Carla M L; Saura, Cristina;
Thistlethwaite, Fiona; Lord, Simon; Moreno, Victor; Macpherson, Iain R;
Boni, Valentina; Rolfo, Christian; De Vries, Elisabeth G E; Rottey,
Sylvie; Geenen, Jill; Eskens, Ferry; Gil-Martin, Marta; Mommers, Ellen
C; Koper, Norbert P; Aftimos, Philippe |
The Lancet Oncology |
2019 |
| 10302 |
10.1016/s1470-2045(19)30515-7 |
Niraparib Plus Bevacizumab Versus Niraparib Alone For
Platinum-Sensitive Recurrent Ovarian Cancer (Nsgo-Avanova2/Engot-Ov24):
A Randomised, Phase 2, Superiority Trial |
Mirza, Mansoor Raza; Avall Lundqvist, Elisabeth;
Birrer, Michael J; Depont Christensen, Rene; Nyvang, Gitte-Bettina;
Malander, Susanne; Anttila, Maarit; Werner, Theresa L; Lund, Bente;
Lindahl, Gabriel; Hietanen, Sakari; Peen, Ulla; Dimoula, Maria; Roed,
Henrik; Or Knudsen, Anja; Staff, Synnove; Krog Vistisen, Anders; Bjorge,
Line; Maenpaa, Johanna U |
The Lancet Oncology |
2019 |
| 10303 |
10.1016/s1470-2045(19)30626-6 |
Nivolumab Versus Chemotherapy In Patients With Advanced
Oesophageal Squamous Cell Carcinoma Refractory Or Intolerant To Previous
Chemotherapy (Attraction-3): A Multicentre, Randomised, Open-Label,
Phase 3 Trial |
Kato, Ken; Cho, Byoung Chul; Takahashi, Masanobu;
Okada, Morihito; Lin, Chen-Yuan; Chin, Keisho; Kadowaki, Shigenori; Ahn,
Myung-Ju; Hamamoto, Yasuo; Doki, Yuichiro; Yen, Chueh-Chuan; Kubota,
Yutaro; Kim, Sung-Bae; Hsu, Chih-Hung; Holtved, Eva; Xynos, Ioannis;
Kodani, Mamoru; Kitagawa, Yuko |
The Lancet Oncology |
2019 |
| 10304 |
10.1016/s1470-2045(19)30634-5 |
Ramucirumab Plus Erlotinib In Patients With Untreated,
Egfr-Mutated, Advanced Non-Small-Cell Lung Cancer (Relay): A Randomised,
Double-Blind, Placebo-Controlled, Phase 3 Trial |
Nakagawa, Kazuhiko; Garon, Edward B; Seto, Takashi;
Nishio, Makoto; Ponce Aix, Santiago; Paz-Ares, Luis; Chiu, Chao-Hua;
Park, Keunchil; Novello, Silvia; Nadal, Ernest; Imamura, Fumio; Yoh,
Kiyotaka; Shih, Jin-Yuan; Au, Kwok Hung; Moro-Sibilot, Denis; Enatsu,
Sotaro; Zimmermann, Annamaria; Frimodt-Moller, Bente; Visseren-Grul,
Carla; Reck, Martin; Chu, Quincy; Cortot, Alexis; Pujol, Jean-Louis;
Moro-Sibilot, Denis; Fabre, Elizabeth; Lamour, Corinne; Bischoff, Helge;
Kollmeier, Jens; Reck, Martin; Kimmich, Martin; Engel-Riedel, Walburga;
Hammerschmidt, Stefan; Schutte, Wolfgang; Syrigos, Konstantinos; Ho,
James Chung Man; Au, Kwok-Hung; Novello, Silvia; Ardizzoni, Andrea;
Pasello, Giulia; Gregorc, Vanessa; Del Conte, Alessandro; Galetta,
Domenico; Takahashi, Toshiaki; Nakagawa, Kazuhiko; Nishio, Makoto; Yoh,
Kiyotaka; Seto, Takashi; Imamura, Fumio; Kumagai, Toru; Hotta,
Katsuyuki; Goto, Yasushi; Hosomi, Yukio; Sakai, Hiroshi; Takiguchi,
Yuichi; Kim, Young Hak; Kurata, Takayasu; Yamaguchi, Hiroyuki; Daga,
Haruko; Okamoto, Isamu; Satouchi, Miyako; Ikeda, Satoshi; Kasahara,
Kazuo; Atagi, Shinji; Azuma, Koichi; Kumagai, Toru; Aoe, Keisuke;
Kumagai, Toru; Aoe, Keisuke; Horio, Yoshitsugu; Yamamoto, Nobuyuki;
Tanaka, Hiroshi; Watanabe, Satoshi; Nogami, Naoyuki; Ozaki, Tomohiro;
Koyama, Ryo; Hirashima, Tomonori; Kaneda, Hiroyasu; Tomii, Keisuke;
Fujita, Yuka; Seike, Masahiro; Nishimura, Naoki; Kato, Terufumi; Ichiki,
Masao; Saka, Hideo; Hirano, Katsuya; Nakahara, Yasuharu; Sugawara,
Shunichi; Park, Keunchil; Kim, Sang-We; Min, Young Joo; Lee, Hyun Woo;
Kang, Jin-Hyoung; An, Ho Jung; Lee, Ki Hyeong; Kim, Jin-Soo; Lee,
Gyeong-Won; Lee, Sung Yong; Alexandru, Aurelia; Udrea, Anghel Adrian;
Juan-Vidal, Oscar; Nadal-Alforja, Ernest; Gil-Bazo, Ignacio; Ponce-Aix,
Santiago; Paz-Ares, Luis; Rubio-Viqueira, Belen; Alonso Garcia, Miriam;
Felip Font, Enriqueta; Fuentes Pradera, Jose; Coves Sarto, Juan; Lin,
Meng-Chih; Su, Wu-Chou; Hsia, Te-Chun; Chang, Gee-Chen; Wei, Yu-Feng;
Chiu, Chao-Hua; Shih, Jin-Yuan; Su, Jian; Cicin, Irfan; Goksel, Tuncay;
Harputluoglu, Hakan; Ozyilkan, Ozgur; Henning, Ivo; Popat, Sanjay;
Hatcher, Olivia; Mileham, Kathryn; Acoba, Jared; Garon, Edward; Jung,
Gabriel; Raj, Moses; Martin, William; Dakhil, Shaker |
The Lancet Oncology |
2019 |
| 10306 |
10.1016/s1470-2045(19)30655-2 |
Lorlatinib In Advanced Ros1-Positive Non-Small-Cell
Lung Cancer: A Multicentre, Open-Label, Single-Arm, Phase
1<U+2013>2 Trial |
Shaw, Alice T; Solomon, Benjamin J; Chiari, Rita;
Riely, Gregory J; Besse, Benjamin; Soo, Ross A; Kao, Steven; Lin,
Chia-Chi; Bauer, Todd M; Clancy, Jill S; Thurm, Holger; Martini,
Jean-Francois; Peltz, Gerson; Abbattista, Antonello; Li, Sherry; Ou,
Sai-Hong Ignatius |
The Lancet Oncology |
2019 |
| 10309 |
10.1016/s1470-2045(19)30689-8 |
Atezolizumab Plus Nab-Paclitaxel As First-Line
Treatment For Unresectable, Locally Advanced Or Metastatic
Triple-Negative Breast Cancer (Impassion130): Updated Efficacy Results
From A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial |
Schmid, Peter; Rugo, Hope S; Adams, Sylvia;
Schneeweiss, Andreas; Barrios, Carlos H; Iwata, Hiroji; Dieras,
Veronique; Henschel, Volkmar; Molinero, Luciana; Chui, Stephen Y; Maiya,
Vidya; Husain, Amreen; Winer, Eric P; Loi, Sherene; Emens, Leisha A |
The Lancet Oncology |
2020 |
| 10310 |
10.1016/s1470-2045(19)30690-4 |
Entrectinib In Ros1 Fusion-Positive Non-Small-Cell Lung
Cancer: Integrated Analysis Of Three Phase 1<U+2013>2 Trials |
Drilon, Alexander; Siena, Salvatore; Dziadziuszko,
Rafal; Barlesi, Fabrice; Krebs, Matthew G; Shaw, Alice T; De Braud,
Filippo; Rolfo, Christian; Ahn, Myung-Ju; Wolf, Jurgen; Seto, Takashi;
Cho, Byoung Chul; Patel, Manish R; Chiu, Chao-Hua; John, Thomas; Goto,
Koichi; Karapetis, Christos S; Arkenau, Hendrick-Tobias; Kim, Sang-We;
Ohe, Yuichiro; Li, Yu-Chung; Chae, Young K; Chung, Christine H;
Otterson, Gregory A; Murakami, Haruyasu; Lin, Chia-Chi; Tan, Daniel S W;
Prenen, Hans; Riehl, Todd; Chow-Maneval, Edna; Simmons, Brian; Cui, Na;
Johnson, Ann; Eng, Susan; Wilson, Timothy R; Doebele, Robert C |
The Lancet Oncology |
2020 |
| 10311 |
10.1016/s1470-2045(19)30691-6 |
Entrectinib In Patients With Advanced Or Metastatic
Ntrk Fusion-Positive Solid Tumours: Integrated Analysis Of Three Phase
1<U+2013>2 Trials |
Doebele, Robert C; Drilon, Alexander; Paz-Ares, Luis;
Siena, Salvatore; Shaw, Alice T; Farago, Anna F; Blakely, Collin M;
Seto, Takashi; Cho, Byung Chul; Tosi, Diego; Besse, Benjamin; Chawla,
Sant P; Bazhenova, Lyudmila; Krauss, John C; Chae, Young Kwang; Barve,
Minal; Garrido-Laguna, Ignacio; Liu, Stephen V; Conkling, Paul; John,
Thomas; Fakih, Marwan; Sigal, Darren; Loong, Herbert H; Buchschacher,
Gary L; Garrido, Pilar; Nieva, Jorge; Steuer, Conor; Overbeck, Tobias R;
Bowles, Daniel W; Fox, Elizabeth; Riehl, Todd; Chow-Maneval, Edna;
Simmons, Brian; Cui, Na; Johnson, Ann; Eng, Susan; Wilson, Timothy R;
Demetri, George D |
The Lancet Oncology |
2020 |
| 10316 |
10.1016/s1470-2045(19)30785-5 |
Osimertinib Plus Savolitinib In Patients With Egfr
Mutation-Positive, Met-Amplified, Non-Small-Cell Lung Cancer After
Progression On Egfr Tyrosine Kinase Inhibitors: Interim Results From A
Multicentre, Open-Label, Phase 1B Study |
Sequist, Lecia V; Han, Ji-Youn; Ahn, Myung-Ju; Cho,
Byoung Chul; Yu, Helena; Kim, Sang-We; Yang, James Chih-Hsin; Lee, Jong
Seok; Su, Wu-Chou; Kowalski, Dariusz; Orlov, Sergey; Cantarini,
Mireille; Verheijen, Remy B; Mellemgaard, Anders; Ottesen, Lone; Frewer,
Paul; Ou, Xiaoling; Oxnard, Geoffrey |
The Lancet Oncology |
2020 |
| 10320 |
10.1016/s1470-2045(19)30856-3 |
Larotrectinib In Patients With Trk Fusion-Positive
Solid Tumours: A Pooled Analysis Of Three Phase 1/2 Clinical Trials |
Hong, David S; Dubois, Steven G; Kummar, Shivaani;
Farago, Anna F; Albert, Catherine M; Rohrberg, Kristoffer S; Van
Tilburg, Cornelis M; Nagasubramanian, Ramamoorthy; Berlin, Jordan D;
Federman, Noah; Mascarenhas, Leo; Geoerger, Birgit; Dowlati, Afshin;
Pappo, Alberto S; Bielack, Stefan; Doz, Francois; Mcdermott, Ray; Patel,
Jyoti D; Schilder, Russell J; Tahara, Makoto; Pfister, Stefan M; Witt,
Olaf; Ladanyi, Marc; Rudzinski, Erin R; Nanda, Shivani; Childs, Barrett
H; Laetsch, Theodore W; Hyman, David M; Drilon, Alexander |
The Lancet Oncology |
2020 |
| 10321 |
10.1016/s1470-2045(19)30863-0 |
Pertuzumab, Trastuzumab, And Docetaxel For
Her2-Positive Metastatic Breast Cancer (Cleopatra): End-Of-Study Results
From A Double-Blind, Randomised, Placebo-Controlled, Phase 3 Study |
Swain, Sandra M; Miles, David; Kim, Sung-Bae; Im,
Young-Hyuck; Im, Seock-Ah; Semiglazov, Vladimir; Ciruelos, Eva;
Schneeweiss, Andreas; Loi, Sherene; Monturus, Estefania; Clark, Emma;
Knott, Adam; Restuccia, Eleonora; Benyunes, Mark C; Cortes, Javier;
Agajanian, Richy; Ahmad, Rizvana; Aktas, Bahriye; Alencar, Victor Hugo;
Amadori, Dino; Andrade, Jurandyr; Andre Franke, Fabio; Angiolini, Catia;
Aogi, Kenjiro; Armor, Jess; Arpornwirat, Wichit; Assersohn, Laura;
Audeh, William; Aulitzky, Walter; Azevedo, Sergio; Bartoli, Maria
Alejandra; Batista Lopez, Norberto; Bianconi, Maria; Biganzoli, Laura;
Birhiray, Ruemu; Bitina, Marianna; Blachy, Ron; Blackwell, Kimberly;
Blanchard, Rita; Blanchet, Paulette; Boiangiu, Ion; Bower, Barbara;
Brezden-Masley, Christine; Brufsky, Adam; Budde, Leanne; Caguioa,
Priscilla; Calvo, Lourdes; Campone, Mario; Carroll, Robert R.; Castro,
Hugo; Chan, Valorie; Charu, Veena; Cinieri, Saverio; Clemens, Michael;
Conejo, Emilio Alba; Cortes, Eduardo; Coudert, Bruno; Cronemberger,
Eduardo; Cubero, Daniel; Dakhil, Shaker; Daniel, Brooke; Davidson,
Neville; De Fatima Gaui, Maria; De La Cruz, Susana; Del Pilar, Maria;
Delgado, Gilson; Ellerton, John A.; Estuardo, Cesar; Fehrenbacher,
Louis; Ferrero, Jean-Marc; Flynn, Patrick J.; Foszczynska-Kloda,
Malgorzata; Franco, Sandra; Fujii, Hirofumi; Gallagher, Chris; Gamucci,
Teresa; Giacomi, Nora; Gil I Gil, Miguel; Gonzalez Martin, Antonio;
Gorbunova, Vera; Gotovkin, Eugeny; Green, Nathan; Grincuka, Elza;
Grischke, Eva-Maria; Hansen, Vincent; Hargis, Jeffrey; Hauschild, Maik;
Hegg, Roberto; Hendricks, Carolyn; Hermann, Robert; Hoff, Paulo;
Horiguchi, Jun; Hornedo Muguiro, Javier; Iacobelli, Stefano; Inoue,
Kenichi; Ismael, Gustavo; Itoh, Yoshinori; Iwata, Dr Hiroji; Jendiroba,
Davi; Jochim, Rosa; Jones, Alison; Just, Marianne; Kallab, Andre;
Karwal, Mark; Kashiwaba, Masahiro; Kato, Giraldo; Kaufman, Peter A.;
Kellokumpu-Lehtinen, Pirkko; Kirsch, Andreas; Kiselev, Igor; Klein,
Paula; Kohno, Norio; Kopp, Mikhail; Kostovska-Maneva, Liljana; Kotliar,
Mauricio; Kudaba, Iveta; Kummel, Sherko; Kuroi, Katsumasa; Lacava, Juan;
Latini, Luciano; Lee, Soo Chin; Lichinitser, Mikhail; Lobo, Christopher;
Maintz, Christoph; Maneecahvakajorn, Jedzada; Marme, Alexander;
Martinez, Gloria; Masuda, Norikazu; Matwiejuk, Mario; Merculov,
Vladimir; Michaelson, Richard; Miguel, Luis; Monroy, Hernandez;
Montemurro, Filippo; Morales, Serafin; Moura, Rodrigo; Mueller, Volkmar;
Mulatero, Clive; Nakagami, Kazuhiko; Nakayama, Takahiro; Neidhart, Jeff;
Nguyen, An; Nishimura, Reiki; Ogata, Haruki; O’Reilly, Susan; O’Rourke,
Timothy; Otero Reye, Douglas; Ouyang, Xuenong; Patel, Ravi; Patel,
Taral; Pedrini, Jose Luiz; Pereira, Rodrigo; Perez, Alejandra; Peterson,
Carol; Pienkowski, Tadeusz; Pinczowski, Helio; Polikoff, Jonathan;
Polkowski, Wojciech; Price, Paola Edith; Prill, Sue; Priou, Frank;
Purkalne, Gunta; Pyrhoenen, Seppo; Quackenbush, Robert; Rai, Yoshiaki;
Ribelles, Nuria; Ro, Jungsil; Robinson, Anne; Robles, Robert; Rodriguez,
Gladys; Roman, Laslo; Saji, Shigehira; Sanchez-Rovira, Pedro; Sato,
Nobuaki; Schmidt, Marcus; Schumacher, Claudia; Senecal, Frank; Sharma,
Priyanka; Shen, Zhenzhou; Shirinkin, Vadim; Simoncini, Edda; Sirisinha,
Thitiya; Smith, Raymond; Sohn, Joo-Hyuk; Soldic, Zeljko; Soria, Tania;
Spicer, Darcy; Srimuninnimit, Vichien; Sriuranpong, Virote;
Staroslawska, Elzbieta; Stefanovski, Petar; Sunpaweravong, Patrapim;
Taguchi, Julie; Takeda, Koji; Tellez-Trevilla, Gabriel; Thomas, Randall;
Thomssen, Christoph; Toache, Zetina; Tokuda, Yutaka; Tomczak, Piotr;
Tosello, Celia; Tsugawa, Koichiro; Tudtud, Dennis; Ueno, Takayuki; Van
Eyll, Brigitte; Varela, Mirta; Vasev, Nikola; Vrbanec, Damir; Wang,
Xiaojia; Wang, Liwei; Watanabe, Junichiro; Waterhouse, David; Wesenberg,
Birgitta; Wheatley, Duncan; Wong, Zee Wan; Yadav, Sanjay; Yadav, Sanjay;
Yardley, Denise; Yau, Tsz-Kok; Yeo, Winnie; Ying, Cheng; Youn Oh,
Do |
The Lancet Oncology |
2020 |
| 10327 |
10.1016/s1470-2045(20)30110-8 |
Camrelizumab Versus Investigator’S Choice Of
Chemotherapy As Second-Line Therapy For Advanced Or Metastatic
Oesophageal Squamous Cell Carcinoma (Escort): A Multicentre, Randomised,
Open-Label, Phase 3 Study |
Huang, Jing; Xu, Jianming; Chen, Yun; Zhuang, Wu;
Zhang, Yiping; Chen, Zhendong; Chen, Jia; Zhang, Helong; Niu, Zuoxing;
Fan, Qingxia; Lin, Lizhu; Gu, Kangsheng; Liu, Ying; Ba, Yi; Miao,
Zhanhui; Jiang, Xiaodong; Zeng, Ming; Chen, Jianhua; Fu, Zhichao; Gan,
Lu; Wang, Jun; Zhan, Xianbao; Liu, Tianshu; Li, Zhiping; Shen, Lin; Shu,
Yongqian; Zhang, Tao; Yang, Qing; Zou, Jianjun; Luo, Suxia; Peng, Feng;
Wu, Gang; Xu, Nong; Zhao, Lin; Ma, Dong; Qin, Shukui; Ren, Wei; Li,
Enxiao; Lu, Hongda; Pan, Yueyin; Xiong, Jianping; Yuan, Ying; Bai,
Yuxian; Chen, Lei; Hu, Yi; Zhang, Li; Gao, Yong |
The Lancet Oncology |
2020 |
| 10328 |
10.1016/s1470-2045(20)30112-1 |
Abemaciclib Plus Trastuzumab With Or Without
Fulvestrant Versus Trastuzumab Plus Standard-Of-Care Chemotherapy In
Women With Hormone Receptor-Positive, Her2-Positive Advanced Breast
Cancer (Monarcher): A Randomised, Open-Label, Phase 2 Trial |
Tolaney, Sara M; Wardley, Andrew M; Zambelli, Stefania;
Hilton, John F; Troso-Sandoval, Tiffany A; Ricci, Francesco; Im,
Seock-Ah; Kim, Sung-Bae; Johnston, Stephen Rd; Chan, Arlene; Goel, Shom;
Catron, Kristen; Chapman, Sonya C; Price, Gregory L; Yang, Zhengyu;
Gainford, M Corona; Andre, Fabrice |
The Lancet Oncology |
2020 |
| 10333 |
10.1016/s1470-2045(20)30169-8 |
First-Line Pembrolizumab And Trastuzumab In
Her2-Positive Oesophageal, Gastric, Or Gastro-Oesophageal Junction
Cancer: An Open-Label, Single-Arm, Phase 2 Trial |
Janjigian, Yelena Y; Maron, Steven B; Chatila, Walid K;
Millang, Brittanie; Chavan, Shweta S; Alterman, Carly; Chou, Joanne F;
Segal, Michal F; Simmons, Marc Z; Momtaz, Parisa; Shcherba, Marina; Ku,
Geoffrey Y; Zervoudakis, Alice; Won, Elizabeth S; Kelsen, David P;
Ilson, David H; Nagy, Rebecca J; Lanman, Richard B; Ptashkin, Ryan N;
Donoghue, Mark T A; Capanu, Marinela; Taylor, Barry S; Solit, David B;
Schultz, Nikolaus; Hechtman, Jaclyn F |
The Lancet Oncology |
2020 |
| 10339 |
10.1016/s1470-2045(20)30324-7 |
Olaparib And Durvalumab In Patients With Germline
Brca-Mutated Metastatic Breast Cancer (Mediola): An Open-Label,
Multicentre, Phase 1/2, Basket Study |
Domchek, Susan M; Postel-Vinay, Sophie; Im, Seock-Ah;
Park, Yeon Hee; Delord, Jean-Pierre; Italiano, Antoine; Alexandre,
Jerome; You, Benoit; Bastian, Sara; Krebs, Matthew G; Wang, Ding; Waqar,
Saiama N; Lanasa, Mark; Rhee, Joon; Gao, Haiyan; Rocher-Ros, Vidalba;
Jones, Emma V; Gulati, Sakshi; Coenen-Stass, Anna; Kozarewa, Iwanka;
Lai, Zhongwu; Angell, Helen K; Opincar, Laura; Herbolsheimer, Pia;
Kaufman, Bella |
The Lancet Oncology |
2020 |
| 10345 |
10.1016/s1470-2045(20)30447-2 |
Veliparib With Carboplatin And Paclitaxel In
Brca-Mutated Advanced Breast Cancer (Brocade3): A Randomised,
Double-Blind, Placebo-Controlled, Phase 3 Trial |
Dieras, Veronique; Han, Hyo S; Kaufman, Bella;
Wildiers, Hans; Friedlander, Michael; Ayoub, Jean-Pierre; Puhalla,
Shannon L; Bondarenko, Igor; Campone, Mario; Jakobsen, Erik H; Jalving,
Mathilde; Oprean, Cristina; Palacova, Marketa; Park, Yeon Hee; Shparyk,
Yaroslav; Yanez, Eduardo; Khandelwal, Nikhil; Kundu, Madan G; Dudley,
Matthew; Ratajczak, Christine K; Maag, David; Arun, Banu K |
The Lancet Oncology |
2020 |
| 10439 |
10.1016/s2213-2600(19)30053-0 |
Alectinib Versus Crizotinib In Untreated Asian Patients
With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer
(Alesia): A Randomised Phase 3 Study |
Zhou, Caicun; Kim, Sang-We; Reungwetwattana, Thanyanan;
Zhou, Jianying; Zhang, Yiping; He, Jianxing; Yang, Jin-Ji; Cheng, Ying;
Lee, Se-Hoon; Bu, Lilian; Xu, Tingting; Yang, Li; Wang, Chao; Liu, Ting;
Morcos, Peter N; Lu, You; Zhang, Li |
The Lancet Respiratory Medicine |
2019 |
| 12642 |
10.1038/s41379-018-0118-3 |
Molecular Characterization Of Cancers With Ntrk Gene
Fusions |
Gatalica, Zoran; Xiu, Joanne; Swensen, Jeffrey; Vranic,
Semir, 0000-0001-9743-7265 |
Modern Pathology |
2018 |
| 12644 |
10.1038/s41379-019-0324-7 |
Ntrk Fusion Detection Across Multiple Assays And 33,997
Cases: Diagnostic Implications And Pitfalls |
Solomon, James P.; Linkov, Irina; Rosado, Andrea;
Mullaney, Kerry; Rosen, Ezra Y.; Frosina, Denise; Jungbluth, Achim A.;
Zehir, Ahmet, 0000-0001-5406-4104; Benayed, Ryma; Drilon, Alexander,
0000-0001-6806-9061; Hyman, David M., 0000-0001-8150-9762; Ladanyi,
Marc; Sireci, Anthony N.; Hechtman, Jaclyn F. |
Modern Pathology |
2019 |
| 12683 |
10.1038/s41416-018-0274-8 |
Candidate Biomarkers Of Parp Inhibitor Sensitivity In
Ovarian Cancer Beyond The Brca Genes |
|
British Journal Of Cancer |
2018 |
| 12686 |
10.1038/s41416-019-0573-8 |
Resistance Mechanisms To Osimertinib In Egfr-Mutated
Non-Small Cell Lung Cancer |
Leonetti, Alessandro; Sharma, Sugandhi; Minari,
Roberta; Perego, Paola; Giovannetti, Elisa; Tiseo, Marcello,
0000-0002-9204-1728 |
British Journal Of Cancer |
2019 |
| 12787 |
10.1038/s41467-018-05564-z |
Methylation Of All Brca1 Copies Predicts Response To
The Parp Inhibitor Rucaparib In Ovarian Carcinoma |
Kondrashova, Olga, 0000-0003-0022-5149; Topp, Monique;
Nesic, Ksenija; Lieschke, Elizabeth; Ho, Gwo-Yaw; Harrell, Maria I.;
Zapparoli, Giada V.; Hadley, Alison; Holian, Robert; Boehm, Emma; Heong,
Valerie; Sanij, Elaine; Pearson, Richard B., 0000-0001-5919-5090; Krais,
John J.; Johnson, Neil; Mcnally, Orla; Ananda, Sumitra; Alsop, Kathryn;
Hutt, Karla J.; Kaufmann, Scott H., 0000-0002-4900-7145; Lin, Kevin K.;
Harding, Thomas C.; Traficante, Nadia; Defazio, Anna; Mcneish, Iain A.,
0000-0002-9387-7586; Bowtell, David D.; Swisher, Elizabeth M.; Dobrovic,
Alexander; Wakefield, Matthew J., 0000-0001-6624-4698; Scott, Clare L.,
0000-0002-3689-5956 |
Nature Communications |
2018 |
| 13106 |
10.1038/s41467-019-11048-5 |
Brca2 Abrogation Triggers Innate Immune Responses
Potentiated By Treatment With Parp Inhibitors |
Reislander, Timo, 0000-0003-0981-8311; Lombardi, Emilia
Puig; Groelly, Florian J.; Miar, Ana; Porru, Manuela; Di Vito, Serena;
Wright, Benjamin; Lockstone, Helen; Biroccio, Annamaria; Harris, Adrian,
0000-0003-1376-8409; Londono-Vallejo, Arturo, 0000-0003-3535-7563;
Tarsounas, Madalena |
Nature Communications |
2019 |
| 13126 |
10.1038/s41467-019-11496-z |
The New-Generation Selective Ros1/Ntrk Inhibitor
Ds-6051B Overcomes Crizotinib Resistant Ros1-G2032R Mutation In
Preclinical Models |
Katayama, Ryohei, 0000-0001-7394-895X; Gong, Bo;
Togashi, Noriko, 0000-0003-2606-0231; Miyamoto, Masaya; Kiga, Masaki;
Iwasaki, Shiho; Kamai, Yasuki; Tominaga, Yuichi; Takeda, Yasuyuki;
Kagoshima, Yoshiko; Shimizu, Yuki; Seto, Yosuke; Oh-Hara, Tomoko; Koike,
Sumie; Nakao, Naoki; Hanzawa, Hiroyuki; Watanabe, Kengo,
0000-0001-7808-1160; Yoda, Satoshi, 0000-0003-4201-1392; Yanagitani,
Noriko; Hata, Aaron N.; Shaw, Alice T.; Nishio, Makoto; Fujita, Naoya;
Isoyama, Takeshi, 0000-0002-2894-5773 |
Nature Communications |
2019 |
| 13282 |
10.1038/s41467-020-15315-8 |
Immunogenomic Profiling Determines Responses To
Combined Parp And Pd-1 Inhibition In Ovarian Cancer |
|
Nature Communications |
2020 |
| 13938 |
10.1038/s41571-018-0113-0 |
Ntrk Fusion-Positive Cancers And Trk Inhibitor
Therapy |
Cocco, Emiliano; Scaltriti, Maurizio; Drilon,
Alexander, 0000-0001-6806-9061 |
Nature Reviews Clinical Oncology |
2018 |
| 14637 |
10.1038/s41591-018-0009-7 |
Carboplatin In Brca1/2-Mutated And Triple-Negative
Breast Cancer Brcaness Subgroups: The Tnt Trial |
Tutt, Andrew, 0000-0001-8715-2901; Tovey, Holly;
Cheang, Maggie Chon U.; Kernaghan, Sarah; Kilburn, Lucy; Gazinska,
Patrycja; Owen, Julie; Abraham, Jacinta; Barrett, Sophie; Barrett-Lee,
Peter; Brown, Robert; Chan, Stephen; Dowsett, Mitchell; Flanagan, James
M; Fox, Lisa; Grigoriadis, Anita, 0000-0003-3434-201X; Gutin, Alexander;
Harper-Wynne, Catherine; Hatton, Matthew Q.; Hoadley, Katherine A.;
Parikh, Jyoti; Parker, Peter; Perou, Charles M.; Roylance, Rebecca;
Shah, Vandna; Shaw, Adam; Smith, Ian E.; Timms, Kirsten M.; Wardley,
Andrew M., 0000-0002-9639-0888; Wilson, Gregory; Gillett, Cheryl;
Lanchbury, Jerry S.; Ashworth, Alan; Rahman, Nazneen; Harries, Mark;
Ellis, Paul; Pinder, Sarah E., 0000-0003-4167-8910; Bliss, Judith
M. |
Nature Medicine |
2018 |
| 14649 |
10.1038/s41591-018-0101-z |
Comprehensive Molecular Characterization Of Clinical
Responses To Pd-1 Inhibition In Metastatic Gastric Cancer |
Kim, Seung Tae; Cristescu, Razvan, 0000-0002-9978-0339;
Bass, Adam J.; Kim, Kyoung-Mee, 0000-0002-1162-9205; Odegaard, Justin
I.; Kim, Kyung, 0000-0002-7712-3135; Liu, Xiao Qiao,
0000-0002-6371-6503; Sher, Xinwei, 0000-0003-3977-3695; Jung, Hun; Lee,
Mijin; Lee, Sujin; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim,
Ho Yeong; Lee, Hyuk; Choi, Mingew; Talasaz, Amirali; Kang, Peter Soonmo;
Cheng, Jonathan; Loboda, Andrey, 0000-0003-4239-184X; Lee, Jeeyun,
0000-0002-4911-6165; Kang, Won Ki |
Nature Medicine |
2018 |
| 14681 |
10.1038/s41591-019-0432-4 |
Immune Induction Strategies In Metastatic
Triple-Negative Breast Cancer To Enhance The Sensitivity To Pd-1
Blockade: The Tonic Trial |
Voorwerk, Leonie; Slagter, Maarten; Horlings, Hugo M.,
0000-0003-4782-8828; Sikorska, Karolina; Van De Vijver, Koen K.,
0000-0002-2026-9790; De Maaker, Michiel; Nederlof, Iris; Kluin, Roelof
J. C.; Warren, Sarah; Ong, Sufey; Wiersma, Terry G.; Russell, Nicola S.,
0000-0003-3507-9620; Lalezari, Ferry; Schouten, Philip C.; Bakker, Noor
A. M.; Ketelaars, Steven L. C.; Peters, Dennis; Lange, Charlotte A. H.;
Van Werkhoven, Erik, 0000-0001-7469-7427; Van Tinteren, Harm; Mandjes,
Ingrid A. M.; Kemper, Inge; Onderwater, Suzanne; Chalabi, Myriam;
Wilgenhof, Sofie; Haanen, John B. A. G., 0000-0001-5884-7704; Salgado,
Roberto; De Visser, Karin E., 0000-0002-0293-868X; Sonke, Gabe S.;
Wessels, Lodewyk F. A.; Linn, Sabine C.; Schumacher, Ton N.,
0000-0003-0517-8804; Blank, Christian U.; Kok, Marleen,
0000-0001-9043-9815 |
Nature Medicine |
2019 |
| 14694 |
10.1038/s41591-019-0542-z |
Resistance To Trk Inhibition Mediated By Convergent
Mapk Pathway Activation |
Cocco, Emiliano; Schram, Alison M.; Kulick, Amanda;
Misale, Sandra; Won, Helen H.; Yaeger, Rona; Razavi, Pedram; Ptashkin,
Ryan; Hechtman, Jaclyn F.; Toska, Eneda; Cownie, James; Somwar, Romel;
Shifman, Sophie; Mattar, Marissa; Selcuklu, S. Duygu; Samoila,
Aliaksandra; Guzman, Sean; Tuch, Brian B.; Ebata, Kevin,
0000-0001-7166-7513; De Stanchina, Elisa; Nagy, Rebecca J.; Lanman,
Richard B., 0000-0001-8122-4329; Houck-Loomis, Brian; Patel, Juber A.;
Berger, Michael F.; Ladanyi, Marc; Hyman, David M., 0000-0001-8150-9762;
Drilon, Alexander, 0000-0001-6806-9061; Scaltriti, Maurizio,
0000-0002-5522-1447 |
Nature Medicine |
2019 |
| 14706 |
10.1038/s41591-019-0716-8 |
Antitumor Activity Of Crizotinib In Lung Cancers
Harboring A Met Exon 14 Alteration |
Drilon, Alexander, 0000-0001-6806-9061; Clark, Jeffrey
W.; Weiss, Jared; Ou, Sai-Hong Ignatius; Camidge, D. Ross; Solomon,
Benjamin J.; Otterson, Gregory A.; Villaruz, Liza C.; Riely, Gregory J.;
Heist, Rebecca S.; Awad, Mark M.; Shapiro, Geoffrey I.; Satouchi,
Miyako; Hida, Toyoaki; Hayashi, Hidetoshi, 0000-0001-8787-5587; Murphy,
Danielle A.; Wang, Sherry C.; Li, Sherry; Usari, Tiziana; Wilner, Keith
D.; Paik, Paul K. |
Nature Medicine |
2020 |
| 14904 |
10.1038/s41598-019-38534-6 |
Niraparib Activates Interferon Signaling And
Potentiates Anti-Pd-1 Antibody Efficacy In Tumor Models |
Wang, Zebin; Sun, Kaiming; Xiao, Yonghong; Feng, Bin;
Mikule, Keith; Ma, Xiaoyan; Feng, Ningping; Vellano, Christopher P.;
Federico, Lorenzo; Marszalek, Joseph R.; Mills, Gordon B.; Hanke,
Jeffrey; Ramaswamy, Sridhar; Wang, Jing |
Scientific Reports |
2019 |
| 16034 |
10.1056/nejmoa1714448 |
Efficacy Of Larotrectinib
Intrkfusion<U+2013>Positive Cancers In Adults And Children |
Drilon, Alexander; Laetsch, Theodore W.; Kummar,
Shivaani; Dubois, Steven G.; Lassen, Ulrik N.; Demetri, George D.;
Nathenson, Michael; Doebele, Robert C.; Farago, Anna F.; Pappo, Alberto
S.; Turpin, Brian; Dowlati, Afshin; Brose, Marcia S.; Mascarenhas, Leo;
Federman, Noah; Berlin, Jordan; El-Deiry, Wafik S.; Baik, Christina;
Deeken, John; Boni, Valentina; Nagasubramanian, Ramamoorthy; Taylor,
Matthew; Rudzinski, Erin R.; Meric-Bernstam, Funda; Sohal, Davendra
P.S.; Ma, Patrick C.; Raez, Luis E.; Hechtman, Jaclyn F.; Benayed, Ryma;
Ladanyi, Marc; Tuch, Brian B.; Ebata, Kevin; Cruickshank, Scott; Ku,
Nora C.; Cox, Michael C.; Hawkins, Douglas S.; Hong, David S.; Hyman,
David M., 0000-0001-8150-9762 |
New England Journal Of Medicine |
2018 |
| 16057 |
10.1056/nejmoa1802905 |
Talazoparib In Patients With Advanced Breast Cancer And
A Germline Brca Mutation |
Litton, Jennifer K.; Rugo, Hope S.; Ettl, Johannes;
Hurvitz, Sara A.; Goncalves, Anthony; Lee, Kyung-Hun; Fehrenbacher,
Louis; Yerushalmi, Rinat; Mina, Lida A.; Martin, Miguel; Roche, Henri;
Im, Young-Hyuck; Quek, Ruben G.W.; Markova, Denka; Tudor, Iulia C.;
Hannah, Alison L.; Eiermann, Wolfgang; Blum, Joanne L. |
New England Journal Of Medicine |
2018 |
| 16069 |
10.1056/nejmoa1809615 |
Atezolizumab And Nab-Paclitaxel In Advanced
Triple-Negative Breast Cancer |
Schmid, Peter; Adams, Sylvia; Rugo, Hope S.;
Schneeweiss, Andreas; Barrios, Carlos H.; Iwata, Hiroji; Dieras,
Veronique; Hegg, Roberto; Im, Seock-Ah; Shaw Wright, Gail; Henschel,
Volkmar; Molinero, Luciana; Chui, Stephen Y.; Funke, Roel; Husain,
Amreen; Winer, Eric P.; Loi, Sherene; Emens, Leisha A. |
New England Journal Of Medicine |
2018 |
| 16073 |
10.1056/nejmoa1810171 |
Brigatinib Versus Crizotinib In Alk-Positive
Non<U+2013>Small-Cell Lung Cancer |
Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang,
James Chih-Hsin; Han, Ji-Youn; Lee, Jong-Seok; Hochmair, Maximilian J.;
Li, Jacky Yu-Chung; Chang, Gee-Chen; Lee, Ki Hyeong; Gridelli, Cesare;
Delmonte, Angelo; Garcia Campelo, Rosario; Kim, Dong-Wan; Bearz,
Alessandra; Griesinger, Frank; Morabito, Alessandro; Felip, Enriqueta;
Califano, Raffaele; Ghosh, Sharmistha; Spira, Alexander; Gettinger,
Scott N.; Tiseo, Marcello; Gupta, Neeraj; Haney, Jeff; Kerstein, David;
Popat, Sanjay |
New England Journal Of Medicine |
2018 |
| 16075 |
10.1056/nejmoa1810858 |
Maintenance Olaparib In Patients With Newly Diagnosed
Advanced Ovarian Cancer |
Moore, Kathleen; Colombo, Nicoletta; Scambia, Giovanni;
Kim, Byoung-Gie; Oaknin, Ana; Friedlander, Michael; Lisyanskaya, Alla;
Floquet, Anne; Leary, Alexandra; Sonke, Gabe S.; Gourley, Charlie;
Banerjee, Susana; Oza, Amit; Gonzalez-Martin, Antonio; Aghajanian,
Carol; Bradley, William; Mathews, Cara; Liu, Joyce; Lowe, Elizabeth S.;
Bloomfield, Ralph; Disilvestro, Paul |
New England Journal Of Medicine |
2018 |
| 16088 |
10.1056/nejmoa1814017 |
Trastuzumab Emtansine For Residual Invasive
Her2-Positive Breast Cancer |
Von Minckwitz, Gunter; Huang, Chiun-Sheng; Mano, Max
S.; Loibl, Sibylle; Mamounas, Eleftherios P.; Untch, Michael; Wolmark,
Norman; Rastogi, Priya; Schneeweiss, Andreas; Redondo, Andres; Fischer,
Hans H.; Jacot, William; Conlin, Alison K.; Arce-Salinas, Claudia;
Wapnir, Irene L.; Jackisch, Christian; Digiovanna, Michael P.; Fasching,
Peter A.; Crown, John P.; Wulfing, Pia; Shao, Zhimin; Rota Caremoli,
Elena; Wu, Haiyan; Lam, Lisa H.; Tesarowski, David; Smitt, Melanie;
Douthwaite, Hannah; Singel, Stina M.; Geyer, Charles E. |
New England Journal Of Medicine |
2019 |
| 16090 |
10.1056/nejmoa1814213 |
Sacituzumab Govitecan-Hziy In Refractory Metastatic
Triple-Negative Breast Cancer |
|
New England Journal Of Medicine |
2019 |
| 16129 |
10.1056/nejmoa1909707 |
Veliparib With First-Line Chemotherapy And As
Maintenance Therapy In Ovarian Cancer |
Coleman, Robert L.; Fleming, Gini F.; Brady, Mark F.;
Swisher, Elizabeth M.; Steffensen, Karina D.; Friedlander, Michael;
Okamoto, Aikou; Moore, Kathleen N.; Efrat Ben-Baruch, Noa; Werner,
Theresa L.; Cloven, Noelle G.; Oaknin, Ana; Disilvestro, Paul A.;
Morgan, Mark A.; Nam, Joo-Hyun; Leath, Charles A.; Nicum, Shibani;
Hagemann, Andrea R.; Littell, Ramey D.; Cella, David; Baron-Hay, Sally;
Garcia-Donas, Jesus; Mizuno, Mika; Bell-Mcguinn, Katherine; Sullivan,
Danielle M.; Bach, Bruce A.; Bhattacharya, Sudipta; Ratajczak, Christine
K.; Ansell, Peter J.; Dinh, Minh H.; Aghajanian, Carol; Bookman, Michael
A. |
New England Journal Of Medicine |
2019 |
| 16134 |
10.1056/nejmoa1910549 |
Pembrolizumab For Early Triple-Negative Breast
Cancer |
|
New England Journal Of Medicine |
2020 |
| 16137 |
10.1056/nejmoa1910962 |
Niraparib In Patients With Newly Diagnosed Advanced
Ovarian Cancer |
|
New England Journal Of Medicine |
2019 |
| 16142 |
10.1056/nejmoa1911361 |
Olaparib Plus Bevacizumab As First-Line Maintenance In
Ovarian Cancer |
Ray-Coquard, Isabelle; Pautier, Patricia; Pignata,
Sandro; Perol, David; Gonzalez-Martin, Antonio; Berger, Regina;
Fujiwara, Keiichi; Vergote, Ignace; Colombo, Nicoletta; Maenpaa,
Johanna; Selle, Frederic; Sehouli, Jalid; Lorusso, Domenica; Guerra
Alia, Eva M.; Reinthaller, Alexander; Nagao, Shoji; Lefeuvre-Plesse,
Claudia; Canzler, Ulrich; Scambia, Giovanni; Lortholary, Alain; Marme,
Frederik; Combe, Pierre; De Gregorio, Nikolaus; Rodrigues, Manuel;
Buderath, Paul; Dubot, Coraline; Burges, Alexander; You, Benoit;
Pujade-Lauraine, Eric; Harter, Philipp |
New England Journal Of Medicine |
2019 |
| 16147 |
10.1056/nejmoa1913662 |
Overall Survival With Osimertinib In Untreated,
Egfr-Mutated Advanced Nsclc |
Ramalingam, Suresh S.; Vansteenkiste, Johan; Planchard,
David; Cho, Byoung Chul; Gray, Jhanelle E.; Ohe, Yuichiro; Zhou, Caicun;
Reungwetwattana, Thanyanan; Cheng, Ying; Chewaskulyong, Busyamas; Shah,
Riyaz; Cobo, Manuel; Lee, Ki Hyeong; Cheema, Parneet; Tiseo, Marcello;
John, Thomas; Lin, Meng-Chih; Imamura, Fumio; Kurata, Takayasu; Todd,
Alexander; Hodge, Rachel; Saggese, Matilde; Rukazenkov, Yuri; Soria,
Jean-Charles |
New England Journal Of Medicine |
2020 |
| 16150 |
10.1056/nejmoa1914510 |
Trastuzumab Deruxtecan In Previously Treated
Her2-Positive Breast Cancer |
Modi, Shanu; Saura, Cristina; Yamashita, Toshinari;
Park, Yeon Hee; Kim, Sung-Bae; Tamura, Kenji; Andre, Fabrice; Iwata,
Hiroji; Ito, Yoshinori; Tsurutani, Junji; Sohn, Joohyuk; Denduluri,
Neelima; Perrin, Christophe; Aogi, Kenjiro; Tokunaga, Eriko; Im,
Seock-Ah; Lee, Keun Seok; Hurvitz, Sara A.; Cortes, Javier; Lee, Caleb;
Chen, Shuquan; Zhang, Lin; Shahidi, Javad; Yver, Antoine; Krop, Ian |
New England Journal Of Medicine |
2020 |
| 16151 |
10.1056/nejmoa1914609 |
Tucatinib, Trastuzumab, And Capecitabine For
Her2-Positive Metastatic Breast Cancer |
Murthy, Rashmi K.; Loi, Sherene; Okines, Alicia;
Paplomata, Elisavet; Hamilton, Erika; Hurvitz, Sara A.; Lin, Nancy U.;
Borges, Virginia; Abramson, Vandana; Anders, Carey; Bedard, Philippe L.;
Oliveira, Mafalda; Jakobsen, Erik; Bachelot, Thomas; Shachar, Shlomit
S.; Muller, Volkmar; Braga, Sofia; Duhoux, Francois P.,
0000-0002-5429-7888; Greil, Richard; Cameron, David; Carey, Lisa A.;
Curigliano, Giuseppe; Gelmon, Karen; Hortobagyi, Gabriel; Krop, Ian;
Loibl, Sibylle; Pegram, Mark; Slamon, Dennis; Palanca-Wessels, M.
Corinna; Walker, Luke; Feng, Wentao; Winer, Eric P. |
New England Journal Of Medicine |
2020 |
| 16165 |
10.1056/nejmoa2002787 |
Capmatinib Inmetexon 14<U+2013>Mutated
Ormet-Amplified Non<U+2013>Small-Cell Lung Cancer |
Wolf, Jurgen; Seto, Takashi; Han, Ji-Youn; Reguart,
Noemi; Garon, Edward B.; Groen, Harry J.M.; Tan, Daniel S.W.; Hida,
Toyoaki; De Jonge, Maja; Orlov, Sergey V.; Smit, Egbert F.; Souquet,
Pierre-Jean; Vansteenkiste, Johan; Hochmair, Maximilian; Felip,
Enriqueta; Nishio, Makoto; Thomas, Michael; Ohashi, Kadoaki; Toyozawa,
Ryo; Overbeck, Tobias R.; De Marinis, Filippo; Kim, Tae-Min,
0000-0001-6145-4426; Laack, Eckart; Robeva, Anna; Le Mouhaer, Sylvie;
Waldron-Lynch, Maeve; Sankaran, Banu; Balbin, O. Alejandro; Cui,
Xiaoming; Giovannini, Monica; Akimov, Mikhail; Heist, Rebecca S. |
New England Journal Of Medicine |
2020 |
| 16169 |
10.1056/nejmoa2004407 |
Tepotinib In Non<U+2013>Small-Cell Lung Cancer
With Met Exon 14 Skipping Mutations |
Paik, Paul K.; Felip, Enriqueta; Veillon, Remi; Sakai,
Hiroshi; Cortot, Alexis B.; Garassino, Marina C.; Mazieres, Julien;
Viteri, Santiago; Senellart, Helene; Van Meerbeeck, Jan; Raskin, Jo;
Reinmuth, Niels; Conte, Pierfranco; Kowalski, Dariusz; Cho, Byoung Chul;
Patel, Jyoti D.; Horn, Leora; Griesinger, Frank; Han, Ji-Youn; Kim,
Young-Chul, 0000-0001-7019-7687; Chang, Gee-Chen; Tsai, Chen-Liang;
Yang, James C.-H.; Chen, Yuh-Min; Smit, Egbert F.; Van Der Wekken,
Anthonie J.; Kato, Terufumi; Juraeva, Dilafruz; Stroh, Christopher;
Bruns, Rolf; Straub, Josef; Johne, Andreas; Scheele, Jurgen; Heymach,
John V.; Le, Xiuning |
New England Journal Of Medicine |
2020 |
| 16170 |
10.1056/nejmoa2004413 |
Trastuzumab Deruxtecan In Previously Treated
Her2-Positive Gastric Cancer |
Shitara, Kohei; Bang, Yung-Jue; Iwasa, Satoru;
Sugimoto, Naotoshi; Ryu, Min-Hee; Sakai, Daisuke; Chung, Hyun-Cheol;
Kawakami, Hisato; Yabusaki, Hiroshi; Lee, Jeeyun; Saito, Kaku;
Kawaguchi, Yoshinori; Kamio, Takahiro; Kojima, Akihito; Sugihara,
Masahiro; Yamaguchi, Kensei |
New England Journal Of Medicine |
2020 |
| 16176 |
10.1056/nejmoa2005651 |
Efficacy Of Selpercatinib In Ret-Altered Thyroid
Cancers |
Wirth, Lori J., 0000-0002-2629-2289; Sherman, Eric;
Robinson, Bruce; Solomon, Benjamin; Kang, Hyunseok, 0000-0001-5758-8202;
Lorch, Jochen; Worden, Francis; Brose, Marcia; Patel, Jyoti; Leboulleux,
Sophie; Godbert, Yann; Barlesi, Fabrice; Morris, John C.; Owonikoko,
Taofeek K.; Tan, Daniel S.W.; Gautschi, Oliver; Weiss, Jared; De La
Fouchardiere, Christelle; Burkard, Mark E.; Laskin, Janessa; Taylor,
Matthew H.; Kroiss, Matthias, 0000-0002-7628-3161; Medioni, Jacques;
Goldman, Jonathan W.; Bauer, Todd M.; Levy, Benjamin; Zhu, Viola W.;
Lakhani, Nehal; Moreno, Victor; Ebata, Kevin; Nguyen, Michele; Heirich,
Dana; Zhu, Edward Y.; Huang, Xin; Yang, Luxi; Kherani, Jennifer;
Rothenberg, S. Michael; Drilon, Alexander; Subbiah, Vivek,
0000-0002-6064-6837; Shah, Manisha H.; Cabanillas, Maria E.,
0000-0002-5124-1811 |
New England Journal Of Medicine |
2020 |
| 16177 |
10.1056/nejmoa2005653 |
Efficacy Of Selpercatinib In Ret
Fusion<U+2013>Positive Non<U+2013>Small-Cell Lung
Cancer |
Drilon, Alexander; Oxnard, Geoffrey R.; Tan, Daniel
S.W.; Loong, Herbert H.F., 0000-0002-6607-1106; Johnson, Melissa;
Gainor, Justin; Mccoach, Caroline E.; Gautschi, Oliver; Besse, Benjamin;
Cho, Byoung C.; Peled, Nir; Weiss, Jared; Kim, Yu-Jung; Ohe, Yuichiro;
Nishio, Makoto; Park, Keunchil; Patel, Jyoti; Seto, Takashi; Sakamoto,
Tomohiro; Rosen, Ezra; Shah, Manisha H.; Barlesi, Fabrice; Cassier,
Philippe A.; Bazhenova, Lyudmila; De Braud, Filippo; Garralda, Elena;
Velcheti, Vamsidhar; Satouchi, Miyako; Ohashi, Kadoaki; Pennell, Nathan
A.; Reckamp, Karen L.; Dy, Grace K.; Wolf, Jurgen; Solomon, Benjamin;
Falchook, Gerald; Ebata, Kevin; Nguyen, Michele; Nair, Binoj; Zhu,
Edward Y.; Yang, Luxi; Huang, Xin; Olek, Elizabeth; Rothenberg, S.
Michael; Goto, Koichi; Subbiah, Vivek, 0000-0002-6064-6837 |
New England Journal Of Medicine |
2020 |
| 16205 |
10.1056/nejmoa2027071 |
Osimertinib In Resected Egfr-Mutated
Non<U+2013>Small-Cell Lung Cancer |
Wu, Yi-Long; Tsuboi, Masahiro; He, Jie; John, Thomas;
Grohe, Christian; Majem, Margarita; Goldman, Jonathan W.; Laktionov,
Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu-Vinh; Lu, Shun; Lee,
Kye-Young; Akewanlop, Charuwan; Yu, Chong-Jen; De Marinis, Filippo;
Bonanno, Laura; Domine, Manuel; Shepherd, Frances A.; Zeng, Lingmin;
Hodge, Rachel; Atasoy, Ajlan; Rukazenkov, Yuri; Herbst, Roy S. |
New England Journal Of Medicine |
2020 |
| 16206 |
10.1056/nejmoa2027187 |
First-Line Lorlatinib Or Crizotinib In Advanced
Alk-Positive Lung Cancer |
Shaw, Alice T.; Bauer, Todd M.; De Marinis, Filippo;
Felip, Enriqueta; Goto, Yasushi; Liu, Geoffrey; Mazieres, Julien; Kim,
Dong-Wan; Mok, Tony; Polli, Anna; Thurm, Holger; Calella, Anna M.;
Peltz, Gerson; Solomon, Benjamin J. |
New England Journal Of Medicine |
2020 |
| 16221 |
10.1056/nejmoa2032125 |
Adjuvant Nivolumab In Resected Esophageal Or
Gastroesophageal Junction Cancer |
Kelly, Ronan J.; Ajani, Jaffer A., 0000-0001-9946-0629;
Kuzdzal, Jaroslaw; Zander, Thomas; Van Cutsem, Eric; Piessen, Guillaume,
0000-0001-8243-8310; Mendez, Guillermo; Feliciano, Josephine; Motoyama,
Satoru; Lievre, Astrid; Uronis, Hope; Elimova, Elena; Grootscholten,
Cecile; Geboes, Karen; Zafar, Syed; Snow, Stephanie; Ko, Andrew H.;
Feeney, Kynan; Schenker, Michael; Kocon, Piotr; Zhang, Jenny; Zhu, Lili;
Lei, Ming; Singh, Prianka; Kondo, Kaoru; Cleary, James M.; Moehler,
Markus |
New England Journal Of Medicine |
2021 |
| 16242 |
10.1056/nejmoa2105215 |
Adjuvant Olaparib For Patients With Brca1- Or
Brca2-Mutated Breast Cancer |
Tutt, Andrew N.J., 0000-0001-8715-2901; Garber, Judy
E.; Kaufman, Bella; Viale, Giuseppe; Fumagalli, Debora; Rastogi, Priya;
Gelber, Richard D.; De Azambuja, Evandro, 0000-0001-9501-4509; Fielding,
Anitra; Balmana, Judith; Domchek, Susan M.; Gelmon, Karen A.;
Hollingsworth, Simon J.; Korde, Larissa A.; Linderholm, Barbro; Bandos,
Hanna; Senkus, El<U+017C>bieta; Suga, Jennifer M.; Shao, Zhimin;
Pippas, Andrew W.; Nowecki, Zbigniew; Huzarski, Tomasz; Ganz, Patricia
A.; Lucas, Peter C.; Baker, Nigel; Loibl, Sibylle; Mcconnell, Robin;
Piccart, Martine; Schmutzler, Rita; Steger, Guenther G.; Costantino,
Joseph P.; Arahmani, Amal; Wolmark, Norman; Mcfadden, Eleanor; Karantza,
Vassiliki; Lakhani, Sunil R.; Yothers, Greg; Campbell, Christine; Geyer,
Charles E., 0000-0002-2379-5702 |
New England Journal Of Medicine |
2021 |
| 16940 |
10.1089/thy.2019.0133 |
Complete Surgical Resection Following Neoadjuvant
Dabrafenib Plus Trametinib Inbrafv600E-Mutated Anaplastic Thyroid
Carcinoma |
Wang, Jennifer R.; Zafereo, Mark E.; Dadu, Ramona;
Ferrarotto, Renata; Busaidy, Naifa L.; Lu, Charles; Ahmed, Salmaan;
Gule-Monroe, Maria K.; Williams, Michelle D.; Sturgis, Erich M.;
Goepfert, Ryan P.; Gross, Neil D.; Lai, Stephen Y.; Gunn, Gary Brandon;
Phan, Jack; Rosenthal, David I.; Fuller, Clifton David; Morrison,
William H.; Iyer, Priyanka; Cabanillas, Maria E. |
Thyroid |
2019 |
| 16959 |
10.1093/annonc/mdy264 |
|
Bang, Y.-J; Ruiz, E.Yanez; Van Cutsem, E.; Lee, K.-W;
Wyrwicz, L.; Schenker, M.; Alsina, M.; Ryu, M.-H; Chung, H.-C; Evesque,
L.; Al-Batran, S.-E; Park, S.H.; Lichinitser, M.; Boku, N.; Moehler,
M.H.; Hong, J.; Xiong, H.; Hallwachs, R.; Conti, I.; Taieb, J. |
Annals Of Oncology |
2018 |
| 16960 |
10.1093/annonc/mdy334 |
Pd-L1 Expression, Tumor Mutational Burden, And Response
To Immunotherapy In Patients With Met Exon 14 Altered Lung Cancers |
Sabari, J.K., 0000-0002-1556-1543; Leonardi, G.C.; Shu,
C.A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad,
C.; Bergagnini, I.; Lai, W.V.; Offin, M.; Arbour, K.C.; Plodkowski,
A.J.; Halpenny, D.F.; Paik, P.K.; Li, B.T.; Riely, G.J.; Kris, M.G.;
Rudin, C.M.; Sholl, L.M.; Nishino, M.; Hellmann, M.D.; Rekhtman, N.;
Awad, M.M.; Drilon, A. |
Annals Of Oncology |
2018 |
| 16961 |
10.1093/annonc/mdy405 |
Alectinib Versus Crizotinib In Treatment-Naive
Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small-Cell Lung Cancer:
Cns Efficacy Results From The Alex Study |
Gadgeel, S.; Peters, S., 0000-0002-0412-7143; Mok, T.;
Shaw, A.T.; Kim, D.W.; Ou, S.I.; Perol, M.; Wrona, A.; Novello, S.;
Rosell, R.; Zeaiter, A.; Liu, T.; Nuesch, E.; Balas, B.; Camidge,
D.R. |
Annals Of Oncology |
2018 |
| 16962 |
10.1093/annonc/mdy424.063 |
Mechanisms Of Acquired Resistance To First-Line
Osimertinib: Preliminary Data From The Phase Iii Flaura Study |
Ramalingam, S.S.; Cheng, Y.; Zhou, C.; Ohe, Y.;
Imamura, F.; Cho, B.C.; Lin, M.-C.; Majem, M.; Shah, R.; Rukazenkov, Y.;
Todd, A.; Markovets, A.; Barrett, J.C.; Chmielecki, J.; Gray, J. |
Annals Of Oncology |
2018 |
| 16963 |
10.1093/annonc/mdy424.064 |
Analysis Of Resistance Mechanisms To Osimertinib In
Patients With Egfr T790M Advanced Nsclc From The Aura3 Study |
Papadimitrakopoulou, V.A.; Wu, Y.-L.; Han, J.-Y.; Ahn,
M.-J.; Ramalingam, S.S.; John, T.; Okamoto, I.; Yang, J.C.-H.; Bulusu,
K.C.; Laus, G.; Collins, B.; Barrett, J.C.; Chmielecki, J.; Mok,
T.S.K. |
Annals Of Oncology |
2018 |
| 16964 |
10.1093/annonc/mdy460 |
|
Loibl, S.; Weber, K.E.; Timms, K.M.; Elkin, E.P.;
Hahnen, E.; Fasching, P.A.; Lederer, B.; Denkert, C.; Schneeweiss, A.;
Braun, S.; Salat, C.T.; Rezai, M.; Blohmer, J.U.; Zahm, D.M.; Jackisch,
C.; Gerber, B.; Klare, P.; Kummel, S.; Schem, C.; Paepke, S.;
Schmutzler, R.; Rhiem, K.; Penn, S.; Reid, J.; Nekljudova, V.; Hartman,
A.-R.; Von Minckwitz, G.; Untch, M. |
Annals Of Oncology |
2018 |
| 16965 |
10.1093/annonc/mdy517 |
Pembrolizumab Monotherapy For Previously Treated
Metastatic Triple-Negative Breast Cancer: Cohort A Of The Phase Ii
Keynote-086 Study |
|
Annals Of Oncology |
2019 |
| 16966 |
10.1093/annonc/mdy518 |
Pembrolizumab Monotherapy For Previously Untreated,
Pd-L1-Positive, Metastatic Triple-Negative Breast Cancer: Cohort B Of
The Phase Ii Keynote-086 Study |
Adams, S.; Loi, S.; Toppmeyer, D.; Cescon, D.W.; De
Laurentiis, M.; Nanda, R.; Winer, E.P.; Mukai, H.; Tamura, K.;
Armstrong, A.; Liu, M.C.; Iwata, H.; Ryvo, L.; Wimberger, P.; Rugo,
H.S.; Tan, A.R.; Jia, L.; Ding, Y.; Karantza, V.; Schmid, P. |
Annals Of Oncology |
2019 |
| 16967 |
10.1093/annonc/mdy539 |
Larotrectinib In Adult Patients With Solid Tumours: A
Multi-Centre, Open-Label, Phase I Dose-Escalation Study |
Hong, D.S.; Bauer, T.M.; Lee, J.J.; Dowlati, A.; Brose,
M.S.; Farago, A.F.; Taylor, M.; Shaw, A.T.; Montez, S.; Meric-Bernstam,
F.; Smith, S.; Tuch, B.B.; Ebata, K.; Cruickshank, S.; Cox, M.C.;
Burris, H.A.; Doebele, R.C. |
Annals Of Oncology |
2019 |
| 16968 |
10.1093/annonc/mdy540 |
Safety And Efficacy Of Nivolumab In Combination With
S-1/Capecitabine Plus Oxaliplatin In Patients With Previously Untreated,
Unresectable, Advanced, Or Recurrent Gastric/Gastroesophageal Junction
Cancer: Interim Results Of A Randomized, Phase Ii Trial
(Attraction-4) |
Boku, N.; Ryu, M.-H.; Kato, K.; Chung, H.C.; Minashi,
K.; Lee, K.-W.; Cho, H.; Kang, W.K.; Komatsu, Y.; Tsuda, M.; Yamaguchi,
K.; Hara, H.; Fumita, S.; Azuma, M.; Chen, L.-T.; Kang, Y.-K. |
Annals Of Oncology |
2019 |
| 16969 |
10.1093/annonc/mdy542 |
Her2 Exon 20 Insertions In Non-Small-Cell Lung Cancer
Are Sensitive To The Irreversible Pan-Her Receptor Tyrosine Kinase
Inhibitor Pyrotinib |
Wang, Y.; Jiang, T.; Qin, Z.; Jiang, J.; Wang, Q.;
Yang, S.; Rivard, C.; Gao, G.; Ng, T.L.; Tu, M.M.; Yu, H.; Ji, H.; Zhou,
C.; Ren, S.; Zhang, J.; Bunn, P.; Doebele, R.C.; Camidge, D.R.; Hirsch,
F.R. |
Annals Of Oncology |
2019 |
| 16970 |
10.1093/annonc/mdy547 |
Prognostic Implications Of Residual Disease
Tumor-Infiltrating Lymphocytes And Residual Cancer Burden In
Triple-Negative Breast Cancer Patients After Neoadjuvant
Chemotherapy |
|
Annals Of Oncology |
2019 |
| 16973 |
10.1093/annonc/mdz012 |
|
Robson, M.E., 0000-0002-3109-1692; Tung, N.; Conte, P.,
0000-0002-5210-5344; Im, S.-A.; Senkus, E.; Xu, B.; Masuda, N.;
Delaloge, S.; Li, W.; Armstrong, A.; Wu, W.; Goessl, C.; Runswick, S.;
Domchek, S.M. |
Annals Of Oncology |
2019 |
| 16974 |
10.1093/annonc/mdz018 |
Overall Survival And Updated Progression-Free Survival
Outcomes In A Randomized Phase Ii Study Of Combination Cediranib And
Olaparib Versus Olaparib In Relapsed Platinum-Sensitive Ovarian
Cancer |
Liu, J.F.; Barry, W.T.; Birrer, M.; Lee, J.-M.;
Buckanovich, R.J.; Fleming, G.F.; Rimel, B.J.; Buss, M.K.; Nattam, S.R.;
Hurteau, J.; Luo, W.; Curtis, J.; Whalen, C.; Kohn, E.C.; Ivy, S.P.;
Matulonis, U.A. |
Annals Of Oncology |
2019 |
| 16976 |
10.1093/annonc/mdz077 |
Severe Immune-Related Adverse Events Are Common With
Sequential Pd-(L)1 Blockade And Osimertinib |
Schoenfeld, A.J., 0000-0002-2644-1416; Arbour, K.C.;
Rizvi, H.; Iqbal, A.N.; Gadgeel, S.M.; Girshman, J.; Kris, M.G.; Riely,
G.J.; Yu, H.A.; Hellmann, M.D. |
Annals Of Oncology |
2019 |
| 16981 |
10.1093/annonc/mdz131 |
Crizotinib In Ros1-Rearranged Advanced Non-Small-Cell
Lung Cancer (Nsclc): Updated Results, Including Overall Survival, From
Profile 1001 |
Shaw, A.T.; Riely, G.J.; Bang, Y.-J.; Kim, D.-W.;
Camidge, D.R.; Solomon, B.J.; Varella-Garcia, M.; Iafrate, A.J.;
Shapiro, G.I.; Usari, T.; Wang, S.C.; Wilner, K.D.; Clark, J.W.; Ou,
S.-H.I. |
Annals Of Oncology |
2019 |
| 16982 |
10.1093/annonc/mdz135 |
Antitumor Activity And Safety Of Pembrolizumab In
Patients With Advanced Recurrent Ovarian Cancer: Results From The Phase
Ii Keynote-100 Study |
Matulonis, U.A.; Shapira-Frommer, R.; Santin, A.D.;
Lisyanskaya, A.S.; Pignata, S.; Vergote, I., 0000-0002-7589-8981;
Raspagliesi, F.; Sonke, G.S.; Birrer, M.; Provencher, D.M.; Sehouli, J.;
Colombo, N.; Gonzalez-Martin, A.; Oaknin, A.; Ottevanger, P.B.;
Rudaitis, V.; Katchar, K.; Wu, H.; Keefe, S.; Ruman, J.; Ledermann,
J.A. |
Annals Of Oncology |
2019 |
| 16983 |
10.1093/annonc/mdz158 |
A Randomised Phase Ii Study Investigating Durvalumab In
Addition To An Anthracycline Taxane-Based Neoadjuvant Therapy In Early
Triple-Negative Breast Cancer: Clinical Results And Biomarker Analysis
Of Geparnuevo Study |
Loibl, S., 0000-0003-4885-8471; Untch, M.; Burchardi,
N.; Huober, J.; Sinn, B.V.; Blohmer, J.-U.; Grischke, E.-M.; Furlanetto,
J.; Tesch, H.; Hanusch, C.; Engels, K.; Rezai, M.; Jackisch, C.;
Schmitt, W.D.; Von Minckwitz, G.; Thomalla, J.; Kummel, S.; Rautenberg,
B.; Fasching, P.A.; Weber, K.; Rhiem, K.; Denkert, C.; Schneeweiss,
A. |
Annals Of Oncology |
2019 |
| 16984 |
10.1093/annonc/mdz167 |
Immune Checkpoint Inhibitors For Patients With Advanced
Lung Cancer And Oncogenic Driver Alterations: Results From The
Immunotarget Registry |
Mazieres, J., 0000-0002-1556-1543; Drilon, A.; Lusque,
A.; Mhanna, L.; Cortot, A.B.; Mezquita, L.; Thai, A.A.; Mascaux, C.;
Couraud, S.; Veillon, R.; Van Den Heuvel, M.; Neal, J.; Peled, N.; Fruh,
M.; Ng, T.L.; Gounant, V.; Popat, S.; Diebold, J.; Sabari, J.; Zhu,
V.W.; Rothschild, S.I.; Bironzo, P.; Martinez-Marti, A.;
Curioni-Fontecedro, A.; Rosell, R.; Lattuca-Truc, M.; Wiesweg, M.;
Besse, B.; Solomon, B.; Barlesi, F.; Schouten, R.D.; Wakelee, H.;
Camidge, D.R.; Zalcman, G.; Novello, S.; Ou, S.I.; Milia, J.; Gautschi,
O. |
Annals Of Oncology |
2019 |
| 16986 |
10.1093/annonc/mdz197 |
Safety, Efficacy And Tumor Mutational Burden As A
Biomarker Of Overall Survival Benefit In Chemo-Refractory Gastric Cancer
Treated With Toripalimab, A Pd-1 Antibody In Phase Ib/Ii Clinical Trial
Nct02915432 |
Wang, F., 0000-0001-9771-8534; Wei, X.L.; Wang, F.H.;
Xu, N.; Shen, L.; Dai, G.H.; Yuan, X.L.; Chen, Y.; Yang, S.J.; Shi,
J.H.; Hu, X.C.; Lin, X.Y.; Zhang, Q.Y.; Feng, J.F.; Ba, Y.; Liu, Y.P.;
Li, W.; Shu, Y.Q.; Jiang, Y.; Li, Q.; Wang, J.W.; Wu, H.; Feng, H.; Yao,
S.; Xu, R.H. |
Annals Of Oncology |
2019 |
| 16987 |
10.1093/annonc/mdz204 |
Esmo Recommendations On The Standard Methods To Detect
Ntrk Fusions In Daily Practice And Clinical Research |
Marchio, C., 0000-0002-5522-1447; Scaltriti, M.;
Ladanyi, M.; Iafrate, A.J.; Bibeau, F.; Dietel, M.; Hechtman, J.F.;
Troiani, T.; Lopez-Rios, F.; Douillard, J.-Y.; Andre, F.; Reis-Filho,
J.S. |
Annals Of Oncology |
2019 |
| 16988 |
10.1093/annonc/mdz282 |
Trk Inhibitors In Trk Fusion-Positive Cancers |
Drilon, A. |
Annals Of Oncology |
2019 |
| 16990 |
10.1093/annonc/mdz384 |
Identifying Patients With Ntrk Fusion Cancer |
Solomon, J.P.; Benayed, R.; Hechtman, J.F.; Ladanyi,
M. |
Annals Of Oncology |
2019 |
| 16992 |
10.1093/annonc/mdz395 |
Prognostic Value Of Tumor-Infiltrating Lymphocytes In
Patients With Early-Stage Triple-Negative Breast Cancers (Tnbc) Who Did
Not Receive Adjuvant Chemotherapy |
Park, J H, 0000-0002-6963-2968; Jonas, S F; Bataillon,
G; Criscitiello, C; Salgado, R; Loi, S; Viale, G; Lee, H J; Dieci, M V;
Kim, S -B; Vincent-Salomon, A; Curigliano, G; Andre, F; Michiels, S |
Annals Of Oncology |
2019 |
| 16996 |
10.1093/annonc/mdz407 |
Crizotinib In C-Met- Or Ros1-Positive Nsclc: Results Of
The Acse Phase Ii Trial |
Moro-Sibilot, D.; Cozic, N.; Perol, M.; Mazieres, J.;
Otto, J.; Souquet, P.J.; Bahleda, R.; Wislez, M.; Zalcman, G.; Guibert,
S.D.; Barlesi, F.; Mennecier, B.; Monnet, I.; Sabatier, R.; Bota, S.;
Dubos, C.; Verriele, V.; Haddad, V.; Ferretti, G.; Cortot, A.; De
Fraipont, F.; Jimenez, M.; Hoog-Labouret, N.; Vassal, G. |
Annals Of Oncology |
2019 |
| 17450 |
10.1097/pas.0000000000001203 |
Expanding The Spectrum Of Pediatric Ntrk-Rearranged
Mesenchymal Tumors |
Davis, Jessica L.; Lockwood, Christina M.; Stohr,
Bradley; Boecking, Carolin; Al-Ibraheemi, Alyaa; Dubois, Steven G.;
Vargas, Sara O.; Black, Jennifer O.; Cox, Michael C.; Luquette, Mark;
Turpin, Brian; Szabo, Sara; Laetsch, Theodore W.; Albert, Catherine M.;
Parham, David M.; Hawkins, Douglas S.; Rudzinski, Erin R. |
American Journal Of Surgical Pathology |
2019 |
| 19087 |
10.1126/scitranslmed.aav4508 |
Cediranib Suppresses Homology-Directed Dna Repair
Through Down-Regulation Of Brca1/2 And Rad51 |
Kaplan, Alanna R., 0000-0002-2612-4736; Gueble, Susan
E., 0000-0002-8043-1147; Liu, Yanfeng; Oeck, Sebastian,
0000-0001-9695-8771; Kim, Hoon; Yun, Zhong, 0000-0003-4123-747X; Glazer,
Peter M., 0000-0003-4525-5560 |
Science Translational Medicine |
2019 |
| 19272 |
10.1136/jclinpath-2018-205679 |
Testing Algorithm For Identification Of Patients With
Trk Fusion Cancer |
Penault-Llorca, Frederique, 0000-0002-4279-5492;
Rudzinski, Erin R; Sepulveda, Antonia R |
Journal Of Clinical Pathology |
2019 |
| 19479 |
10.1158/0008-5472.can-18-1003 |
Parpi Triggers The Sting-Dependent Immune Response And
Enhances The Therapeutic Efficacy Of Immune Checkpoint Blockade
Independent Of Brcaness |
Shen, Jianfeng; Zhao, Wei; Ju, Zhenlin; Wang, Lulu;
Peng, Yang; Labrie, Marilyne; Yap, Timothy A.; Mills, Gordon B.; Peng,
Guang |
Cancer Research |
2018 |
| 19480 |
10.1158/0008-5472.can-18-2652 |
Development Of Parp And Immune-Checkpoint Inhibitor
Combinations |
Stewart, Ross A; Pilie, Patrick G; Yap, Timothy A |
Cancer Research |
2018 |
| 19485 |
10.1158/0008-5472.can-18-3126 |
Colorectal Carcinomas Containing Hypermethylated Mlh1
Promoter And Wild-Type Braf/Kras Are Enriched For Targetable Kinase
Fusions |
Cocco, Emiliano; Benhamida, Jamal; Middha, Sumit;
Zehir, Ahmet, 0000-0001-5406-4104; Mullaney, Kerry; Shia, Jinru; Yaeger,
Rona; Zhang, Liying, 0000-0003-4517-0751; Wong, Donna,
0000-0001-8154-0858; Villafania, Liliana; Nafa, Khedoudja; Scaltriti,
Maurizio; Drilon, Alexander, 0000-0001-6806-9061; Saltz, Leonard,
0000-0001-8353-4670; Schram, Alison M., 0000-0002-6070-2413; Stadler,
Zsofia K.; Hyman, David M.; Benayed, Ryma; Ladanyi, Marc; Hechtman,
Jaclyn F. |
Cancer Research |
2019 |
| 19489 |
10.1158/0008-5472.can-19-0372 |
Detection Of Ntrk Fusions: Merits And Limitations Of
Current Diagnostic Platforms |
Solomon, James P.; Hechtman, Jaclyn F. |
Cancer Research |
2019 |
| 19499 |
10.1158/1078-0432.ccr-18-1542 |
Landscape Of Egfr-Dependent And -Independent Resistance
Mechanisms To Osimertinib And Continuation Therapy Beyond Progression In
Egfr-Mutant Nsclc |
Le, Xiuning; Puri, Sonam; Negrao, Marcelo V.; Nilsson,
Monique B.; Robichaux, Jacqulyne; Boyle, Theresa; Hicks, J. Kevin,
0000-0003-2314-0164; Lovinger, Katherine L.; Roarty, Emily;
Rinsurongkawong, Waree; Tang, Ming; Sun, Huiying; Elamin, Yasir;
Lacerda, Lara C.; Lewis, Jeff; Roth, Jack A.; Swisher, Stephen G.,
0000-0002-3080-1920; Lee, J. Jack; William, William N.; Glisson, Bonnie
S.; Zhang, Jianjun; Papadimitrakopoulou, Vassiliki A.; Gray, Jhanelle
E.; Heymach, John V., 0000-0001-9068-8942 |
Clinical Cancer Research |
2018 |
| 19506 |
10.1158/1078-0432.ccr-18-2814 |
Capmatinib (Inc280) Is Active Against Models Of
Non<U+2013>Small Cell Lung Cancer And Other Cancer Types With
Defined Mechanisms Of Met Activation |
Baltschukat, Sabrina; Engstler, Barbara Schacher;
Huang, Alan; Hao, Huai-Xiang; Tam, Angela; Wang, Hui Qin; Liang,
Jinsheng; Dimare, Matthew T.; Bhang, Hyo-Eun Carrie; Wang, Youzhen;
Furet, Pascal; Sellers, William R., 0000-0002-3539-9803; Hofmann,
Francesco; Schoepfer, Joseph, 0000-0001-7935-1767; Tiedt, Ralph |
Clinical Cancer Research |
2019 |
| 19511 |
10.1158/1078-0432.ccr-19-0225 |
High Yield Of Rna Sequencing For Targetable Kinase
Fusions In Lung Adenocarcinomas With No Mitogenic Driver Alteration
Detected By Dna Sequencing And Low Tumor Mutation Burden |
Benayed, Ryma, 0000-0002-3754-0321; Offin, Michael,
0000-0002-7959-3018; Mullaney, Kerry; Sukhadia, Purvil,
0000-0002-6079-0871; Rios, Kelly, 0000-0001-7596-0741; Desmeules,
Patrice; Ptashkin, Ryan, 0000-0003-4275-5500; Won, Helen; Chang, Jason;
Halpenny, Darragh; Schram, Alison M., 0000-0002-6070-2413; Rudin,
Charles M., 0000-0001-5204-3465; Hyman, David M.; Arcila, Maria E.;
Berger, Michael F.; Zehir, Ahmet, 0000-0001-5406-4104; Kris, Mark G.;
Drilon, Alexander, 0000-0001-6806-9061; Ladanyi, Marc |
Clinical Cancer Research |
2019 |
| 19513 |
10.1158/1078-0432.ccr-19-0994 |
Crizotinib In Met-Deregulated Or Ros1-Rearranged
Pretreated Non<U+2013>Small Cell Lung Cancer (Metros): A Phase Ii,
Prospective, Multicenter, Two-Arms Trial |
Landi, Lorenza; Chiari, Rita; Tiseo, Marcello; D’Inca,
Federica; Dazzi, Claudio; Chella, Antonio; Delmonte, Angelo; Bonanno,
Laura, 0000-0001-5218-4970; Giannarelli, Diana; Cortinovis, Diego Luigi;
De Marinis, Filippo; Borra, Gloria; Morabito, Alessandro; Gridelli,
Cesare; Galetta, Domenico; Barbieri, Fausto; Grossi, Francesco;
Capelletto, Enrica, 0000-0003-2070-9335; Minuti, Gabriele; Mazzoni,
Francesca; Verusio, Claudio, 0000-0003-3283-6868; Bria, Emilio,
0000-0002-2333-704X; Ali, Greta; Bruno, Rossella, 0000-0003-4965-1501;
Proietti, Agnese; Fontanini, Gabriella; Crino, Lucio; Cappuzzo,
Federico |
Clinical Cancer Research |
2019 |
| 19520 |
10.1158/1078-0432.ccr-19-3563 |
Tumor Analyses Reveal Squamous Transformation And
Off-Target Alterations As Early Resistance Mechanisms To First-Line
Osimertinib In Egfr-Mutant Lung Cancer |
Schoenfeld, Adam J., 0000-0002-2644-1416; Chan, Joseph
M.; Kubota, Daisuke; Sato, Hiroki; Rizvi, Hira; Daneshbod, Yahya; Chang,
Jason C.; Paik, Paul K.; Offin, Michael, 0000-0002-7959-3018; Arcila,
Maria E.; Davare, Monika A.; Shinde, Ujwal; Pe’Er, Dana; Rekhtman,
Natasha, 0000-0001-5801-3144; Kris, Mark G.; Somwar, Romel; Riely,
Gregory J.; Ladanyi, Marc; Yu, Helena A. |
Clinical Cancer Research |
2020 |
| 19528 |
10.1158/2159-8290.cd-18-0484 |
Repotrectinib (Tpx-0005) Is A Next-Generation
Ros1/Trk/Alk Inhibitor That Potently Inhibits Ros1/Trk/Alk Solvent-
Front Mutations |
Drilon, Alexander; Ou, Sai-Hong Ignatius; Cho, Byoung
Chul; Kim, Dong-Wan; Lee, Jeeyun; Lin, Jessica J., 0000-0001-7373-3916;
Zhu, Viola W.; Ahn, Myung-Ju; Camidge, D. Ross; Nguyen, Judy; Zhai,
Dayong; Deng, Wei; Huang, Zhongdong; Rogers, Evan; Liu, Juliet; Whitten,
Jeff; Lim, John K.; Stopatschinskaja, Shanna; Hyman, David M.; Doebele,
Robert C., 0000-0001-6728-6857; Cui, J. Jean; Shaw, Alice T. |
Cancer Discovery |
2018 |
| 19529 |
10.1158/2159-8290.cd-18-0598 |
Egfr And Met Amplifications Determine Response To Her2
Inhibition In Erbb2-Amplified Esophagogastric Cancer |
Sanchez-Vega, Francisco; Hechtman, Jaclyn F.; Castel,
Pau; Ku, Geoffrey Y., 0000-0002-0448-1038; Tuvy, Yaelle; Won, Helen;
Fong, Christopher J.; Bouvier, Nancy; Nanjangud, Gouri J.; Soong,
Joanne; Vakiani, Efsevia; Schattner, Mark; Kelsen, David P.; Lefkowitz,
Robert A.; Brown, Karen; Lacouture, Mario E.; Capanu, Marinela; Mattar,
Marissa; Qeriqi, Besnik; Cecchi, Fabiola; Tian, Yuan; Hembrough, Todd;
Nagy, Rebecca J.; Lanman, Richard B., 0000-0001-8122-4329; Larson,
Steven M.; Pandit-Taskar, Neeta; Schoder, Heiko; Iacobuzio-Donahue,
Christine A., 0000-0002-4672-3023; Ilson, David H.; Weber, Wolfgang A.;
Berger, Michael F.; De Stanchina, Elisa; Taylor, Barry S.; Lewis, Jason
S., 0000-0001-7065-4534; Solit, David B.; Carrasquillo, Jorge A.;
Scaltriti, Maurizio; Schultz, Nikolaus; Janjigian, Yelena Y. |
Cancer Discovery |
2018 |
| 19531 |
10.1158/2159-8290.cd-18-0715 |
Brca Reversion Mutations In Circulating Tumor Dna
Predict Primary And Acquired Resistance To The Parp Inhibitor Rucaparib
In High-Grade Ovarian Carcinoma |
Lin, Kevin K.; Harrell, Maria I.; Oza, Amit M.; Oaknin,
Ana; Ray-Coquard, Isabelle; Tinker, Anna V.; Helman, Elena; Radke, Marc
R.; Say, Carmen; Vo, Lan-Thanh; Mann, Elaina; Isaacson, Jeffrey D.;
Maloney, Lara; O’Malley, David M.; Chambers, Setsuko K.; Kaufmann, Scott
H., 0000-0002-4900-7145; Scott, Clare L.; Konecny, Gottfried E.;
Coleman, Robert L.; Sun, James X.; Giordano, Heidi; Brenton, James D.,
0000-0002-5738-6683; Harding, Thomas C.; Mcneish, Iain A.,
0000-0002-9387-7586; Swisher, Elizabeth M. |
Cancer Discovery |
2018 |
| 19536 |
10.1158/2159-8290.cd-18-1020 |
Targeting Dna Damage Response Promotes Antitumor
Immunity Through Sting-Mediated T-Cell Activation In Small Cell Lung
Cancer |
Sen, Triparna; Rodriguez, B. Leticia; Chen, Limo;
Corte, Carminia M. Della; Morikawa, Naoto; Fujimoto, Junya; Cristea,
Sandra; Nguyen, Thuyen; Diao, Lixia; Li, Lerong; Fan, Youhong; Yang,
Yongbin; Wang, Jing; Glisson, Bonnie S.; Wistuba, Ignacio I.; Sage,
Julien, 0000-0002-8928-9968; Heymach, John V., 0000-0001-9068-8942;
Gibbons, Don L.; Byers, Lauren A. |
Cancer Discovery |
2019 |
| 19537 |
10.1158/2159-8290.cd-18-1022 |
Landscape Of Acquired Resistance To Osimertinib In
Egfr-Mutant Nsclc And Clinical Validation Of Combined Egfr And Ret
Inhibition With Osimertinib And Blu-667 For Acquired Ret Fusion |
Piotrowska, Zofia; Isozaki, Hideko; Lennerz, Jochen K.;
Gainor, Justin F.; Lennes, Inga T.; Zhu, Viola W.; Marcoux, Nicolas,
0000-0003-1422-6716; Banwait, Mandeep K.; Digumarthy, Subba R.; Su,
Wenjia; Yoda, Satoshi, 0000-0003-4201-1392; Riley, Amanda K.; Nangia,
Varuna; Lin, Jessica J., 0000-0001-7373-3916; Nagy, Rebecca J.; Lanman,
Richard B., 0000-0001-8122-4329; Dias-Santagata, Dora; Mino-Kenudson,
Mari; Iafrate, A. John; Heist, Rebecca S.; Shaw, Alice T.; Evans, Erica
K.; Clifford, Corinne; Ou, Sai-Hong I.; Wolf, Beni; Hata, Aaron N.;
Sequist, Lecia V., 0000-0002-8965-6991 |
Cancer Discovery |
2018 |
| 19539 |
10.1158/2159-8290.cd-18-1218 |
Parp Inhibitor Efficacy Depends On Cd8+ T-Cell
Recruitment Via Intratumoral Sting Pathway Activation In Brca-Deficient
Models Of Triple-Negative Breast Cancer |
Pantelidou, Constantia; Sonzogni, Olmo,
0000-0001-5697-8102; De Oliveria Taveira, Mateus; Mehta, Anita K.;
Kothari, Aditi; Wang, Dan; Visal, Tanvi; Li, Michelle K.; Pinto,
Jocelin; Castrillon, Jessica A.; Cheney, Emily M.; Bouwman, Peter;
Jonkers, Jos, 0000-0002-9264-9792; Rottenberg, Sven; Guerriero, Jennifer
L., 0000-0002-2104-5457; Wulf, Gerburg M.; Shapiro, Geoffrey I. |
Cancer Discovery |
2019 |
| 19551 |
10.1158/2159-8290.cd-19-0582 |
Combination Olaparib And Temozolomide In Relapsed
Small-Cell Lung Cancer |
Farago, Anna F.; Yeap, Beow Y.; Stanzione, Marcello;
Hung, Yin P., 0000-0002-8568-1591; Heist, Rebecca S.; Marcoux, J. Paul;
Zhong, Jun; Rangachari, Deepa; Barbie, David A.; Phat, Sarah; Myers,
David T.; Morris, Robert; Kem, Marina; Dubash, Taronish D.; Kennedy,
Elizabeth A.; Digumarthy, Subba R., 0000-0003-4041-6716; Sequist, Lecia
V., 0000-0002-8965-6991; Hata, Aaron N.; Maheswaran, Shyamala; Haber,
Daniel A.; Lawrence, Michael S.; Shaw, Alice T.; Mino-Kenudson, Mari,
0000-0002-9092-2265; Dyson, Nicholas J.; Drapkin, Benjamin J. |
Cancer Discovery |
2019 |
| 19558 |
10.1158/2159-8290.cd-19-1014 |
Targeting Her2 With Trastuzumab Deruxtecan: A
Dose-Expansion, Phase I Study In Multiple Advanced Solid Tumors |
Tsurutani, Junji, 0000-0002-6260-6943; Iwata, Hiroji,
0000-0002-0242-4718; Krop, Ian; Janne, Pasi A.; Doi, Toshihiko;
Takahashi, Shunji; Park, Haeseong; Redfern, Charles; Tamura, Kenji,
0000-0002-3514-9927; Wise-Draper, Trisha M.; Saito, Kaku; Sugihara,
Masahiro; Singh, Jasmeet; Jikoh, Takahiro; Gallant, Gilles; Li, Bob T.,
0000-0001-6661-8733 |
Cancer Discovery |
2020 |
| 19748 |
10.1172/jci123319 |
Parp Inhibition Enhances Tumor
Cell<U+2013>Intrinsic Immunity In Ercc1-Deficient
Non<U+2013>Small Cell Lung Cancer |
Chabanon, Roman M.; Muirhead, Gareth; Krastev, Dragomir
B., 0000-0003-4298-7272; Adam, Julien; Morel, Daphne,
0000-0002-9121-4973; Garrido, Marlene, 0000-0001-7492-0879; Lamb,
Andrew; Henon, Clemence; Dorvault, Nicolas; Rouanne, Mathieu,
0000-0003-2970-4821; Marlow, Rebecca, 0000-0001-7525-7968; Bajrami,
Ilirjana; Cardenosa, Marta Llorca; Konde, Asha; Besse, Benjamin;
Ashworth, Alan; Pettitt, Stephen J., 0000-0003-3313-3857; Haider, Syed;
Marabelle, Aurelien, 0000-0002-5816-3019; Tutt, Andrew N.J.,
0000-0001-8715-2901; Soria, Jean-Charles; Lord, Christopher J.,
0000-0002-3226-0515; Postel-Vinay, Sophie |
Journal Of Clinical Investigation |
2019 |
| 20016 |
10.1186/s12885-019-5380-3 |
Safety And Antitumor Activity Of The
Anti<U+2013>Pd-1 Antibody Pembrolizumab In Patients With Advanced,
Pd-L1<U+2013>Positive Papillary Or Follicular Thyroid Cancer |
Mehnert, Janice M.; Varga, Andrea; Brose, Marcia S.;
Aggarwal, Rahul R.; Lin, Chia-Chi; Prawira, Amy; De Braud, Filippo;
Tamura, Kenji; Doi, Toshihiko; Piha-Paul, Sarina A.; Gilbert, Jill;
Saraf, Sanatan; Thanigaimani, Pradeep; Cheng, Jonathan D.; Keam,
Bhumsuk |
Bmc Cancer |
2019 |
| 20190 |
10.1186/s40425-019-0514-3 |
Clinicopathological And Molecular Features Of
Responders To Nivolumab For Patients With Advanced Gastric Cancer |
Mishima, Saori; Kawazoe, Akihito; Nakamura, Yoshiaki;
Sasaki, Akinori; Kotani, Daisuke; Kuboki, Yasutoshi; Bando, Hideaki;
Kojima, Takashi; Doi, Toshihiko; Ohtsu, Atsushi; Yoshino, Takayuki;
Kuwata, Takeshi; Tsuji, Akihito; Shitara, Kohei |
Journal For Immunotherapy Of Cancer |
2019 |
| 20212 |
10.1200/jco.18.00131 |
Select: A Phase Ii Trial Of Adjuvant Erlotinib In
Patients With Resected Epidermal Growth Factor
Receptor<U+2013>Mutant Non<U+2013>Small-Cell Lung
Cancer |
Pennell, Nathan A.; Neal, Joel W.; Chaft, Jamie E.;
Azzoli, Christopher G.; Janne, Pasi A.; Govindan, Ramaswamy; Evans,
Tracey L.; Costa, Daniel B.; Wakelee, Heather A.; Heist, Rebecca S.;
Shapiro, Marc A.; Muzikansky, Alona; Murthy, Sudish; Lanuti, Michael;
Rusch, Valerie W.; Kris, Mark G.; Sequist, Lecia V. |
Journal Of Clinical Oncology |
2019 |
| 20214 |
10.1200/jco.18.00264 |
Randomized Phase Ii Trial Of Cisplatin And Etoposide In
Combination With Veliparib Or Placebo For Extensive-Stage Small-Cell
Lung Cancer: Ecog-Acrin 2511 Study |
Owonikoko, Taofeek K.; Dahlberg, Suzanne E.; Sica,
Gabriel L.; Wagner, Lynne I.; Wade, James L.; Srkalovic, Gordan; Lash,
Bradley W.; Leach, Joseph W.; Leal, Ticiana B.; Aggarwal, Charu;
Ramalingam, Suresh S. |
Journal Of Clinical Oncology |
2019 |
| 20221 |
10.1200/jco.18.01010 |
Tumor-Infiltrating Lymphocytes And Prognosis: A Pooled
Individual Patient Analysis Of Early-Stage Triple-Negative Breast
Cancers |
Loi, Sherene; Drubay, Damien; Adams, Sylvia; Pruneri,
Giancarlo; Francis, Prudence A.; Lacroix-Triki, Magali; Joensuu, Heikki;
Dieci, Maria Vittoria; Badve, Sunil; Demaria, Sandra; Gray, Robert;
Munzone, Elisabetta; Lemonnier, Jerome; Sotiriou, Christos; Piccart,
Martine J.; Kellokumpu-Lehtinen, Pirkko-Liisa; Vingiani, Andrea; Gray,
Kathryn; Andre, Fabrice; Denkert, Carsten; Salgado, Roberto; Michiels,
Stefan |
Journal Of Clinical Oncology |
2019 |
| 20226 |
10.1200/jco.18.01511 |
Tbcrc 022: A Phase Ii Trial Of Neratinib And
Capecitabine For Patients With Human Epidermal Growth Factor Receptor
2<U+2013>Positive Breast Cancer And Brain Metastases |
|
Journal Of Clinical Oncology |
2019 |
| 20227 |
10.1200/jco.18.01568 |
Randomized Trial Of Intravenous Versus Intraperitoneal
Chemotherapy Plus Bevacizumab In Advanced Ovarian Carcinoma: An Nrg
Oncology/Gynecologic Oncology Group Study |
Walker, Joan L.; Brady, Mark F.; Wenzel, Lari; Fleming,
Gini F.; Huang, Helen Q.; Disilvestro, Paul A.; Fujiwara, Keiichi;
Alberts, David S.; Zheng, Wenxin; Tewari, Krishnansu S.; Cohn, David E.;
Powell, Matthew A.; Van Le, Linda; Davidson, Susan A.; Gray, Heidi J.;
Rose, Peter G.; Aghajanian, Carol; Myers, Tashanna; Alvarez Secord,
Angeles; Rubin, Stephen C.; Mannel, Robert S. |
Journal Of Clinical Oncology |
2019 |
| 20231 |
10.1200/jco.18.01585 |
Egfr-Mutant Adenocarcinomas That Transform To
Small-Cell Lung Cancer And Other Neuroendocrine Carcinomas: Clinical
Outcomes |
|
Journal Of Clinical Oncology |
2019 |
| 20236 |
10.1200/jco.18.02236 |
Alk Resistance Mutations And Efficacy Of Lorlatinib In
Advanced Anaplastic Lymphoma Kinase-Positive Non<U+2013>Small-Cell
Lung Cancer |
Shaw, Alice T.; Solomon, Benjamin J.; Besse, Benjamin;
Bauer, Todd M.; Lin, Chia-Chi; Soo, Ross A.; Riely, Gregory J.; Ou,
Sai-Hong Ignatius; Clancy, Jill S.; Li, Sherry; Abbattista, Antonello;
Thurm, Holger; Satouchi, Miyako; Camidge, D. Ross; Kao, Steven; Chiari,
Rita; Gadgeel, Shirish M.; Felip, Enriqueta; Martini, Jean-Francois |
Journal Of Clinical Oncology |
2019 |
| 20240 |
10.1200/jco.19.00066 |
Seven-Year Follow-Up Analysis Of Adjuvant Paclitaxel
And Trastuzumab Trial For Node-Negative, Human Epidermal Growth Factor
Receptor 2<U+2013>Positive Breast Cancer |
Tolaney, Sara M.; Guo, Hao; Pernas, Sonia; Barry,
William T.; Dillon, Deborah A.; Ritterhouse, Lauren; Schneider, Bryan
P.; Shen, Fei; Fuhrman, Kit; Baltay, Michele; Dang, Chau T.; Yardley,
Denise A.; Moy, Beverly; Marcom, P. Kelly; Albain, Kathy S.; Rugo, Hope
S.; Ellis, Mathew J.; Shapira, Iuliana; Wolff, Antonio C.; Carey, Lisa
A.; Overmoyer, Beth; Partridge, Ann H.; Hudis, Clifford A.; Krop, Ian
E.; Burstein, Harold J.; Winer, Eric P. |
Journal Of Clinical Oncology |
2019 |
| 20241 |
10.1200/jco.19.00075 |
Erlotinib Versus Gemcitabine Plus Cisplatin As
Neoadjuvant Treatment Of Stage Iiia-N2 Egfr-Mutant
Non<U+2013>Small-Cell Lung Cancer (Emerging-Ctong 1103): A
Randomized Phase Ii Study |
Zhong, Wen-Zhao; Chen, Ke-Neng; Chen, Chun; Gu,
Chun-Dong; Wang, Jun; Yang, Xue-Ning; Mao, Wei-Min; Wang, Qun; Qiao,
Gui-Bin; Cheng, Ying; Xu, Lin; Wang, Chang-Li; Chen, Ming-Wei; Kang,
Xiaozheng; Yan, Wanpu; Yan, Hong-Hong; Liao, Ri-Qiang; Yang, Jin-Ji;
Zhang, Xu-Chao; Zhou, Qing; Wu, Yi-Long |
Journal Of Clinical Oncology |
2019 |
| 20242 |
10.1200/jco.19.00108 |
Pyrotinib Or Lapatinib Combined With Capecitabine In
Her2<U+2013>Positive Metastatic Breast Cancer With Prior Taxanes,
Anthracyclines, And/Or Trastuzumab: A Randomized, Phase Ii Study |
Ma, Fei; Ouyang, Quchang; Li, Wei; Jiang, Zefei; Tong,
Zhongsheng; Liu, Yunjiang; Li, Huiping; Yu, Shiying; Feng, Jifeng; Wang,
Shusen; Hu, Xichun; Zou, Jianjun; Zhu, Xiaoyu; Xu, Binghe |
Journal Of Clinical Oncology |
2019 |
| 20249 |
10.1200/jco.19.00457 |
Osimertinib In Patients With Epidermal Growth Factor
Receptor Mutation<U+2013>Positive Non<U+2013>Small-Cell Lung
Cancer And Leptomeningeal Metastases: The Bloom Study |
Yang, James C.H.; Kim, Sang-We; Kim, Dong-Wan; Lee,
Jong-Seok; Cho, Byoung Chul; Ahn, Jin-Seok; Lee, Dae H.; Kim, Tae Min;
Goldman, Jonathan W.; Natale, Ronald B.; Brown, Andrew P.; Collins,
Barbara; Chmielecki, Juliann; Vishwanathan, Karthick; Mendoza-Naranjo,
Ariadna; Ahn, Myung-Ju |
Journal Of Clinical Oncology |
2020 |
| 20252 |
10.1200/jco.19.00882 |
Neoadjuvant Trastuzumab Emtansine And Pertuzumab In
Human Epidermal Growth Factor Receptor 2<U+2013>Positive Breast
Cancer: Three-Year Outcomes From The Phase Iii Kristine Study |
Hurvitz, Sara A.; Martin, Miguel; Jung, Kyung Hae;
Huang, Chiun-Sheng; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy,
Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-Francois;
Fasching, Peter A.; Afenjar, Karen; Spera, Gonzalo; Lopez-Valverde,
Vanesa; Song, Chunyan; Trask, Peter; Boulet, Thomas; Sparano, Joseph A.;
Symmans, W. Fraser; Thompson, Alastair M.; Slamon, Dennis |
Journal Of Clinical Oncology |
2019 |
| 20254 |
10.1200/jco.19.00931 |
Osimertinib For Patients With
Non<U+2013>Small-Cell Lung Cancer Harboring Uncommon Egfr
Mutations: A Multicenter, Open-Label, Phase Ii Trial (Kcsg-Lu15-09) |
Cho, Jang Ho; Lim, Sung Hee; An, Ho Jung; Kim, Ki Hwan;
Park, Keon Uk; Kang, Eun Joo; Choi, Yoon Hee; Ahn, Mi Sun; Lee, Myung
Hee; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn,
Myung-Ju |
Journal Of Clinical Oncology |
2020 |
| 20255 |
10.1200/jco.19.01009 |
Final Overall Survival Of A Randomized Trial Of
Bevacizumab For Primary Treatment Of Ovarian Cancer |
Tewari, Krishnansu S.; Burger, Robert A.; Enserro,
Danielle; Norquist, Barbara M.; Swisher, Elizabeth M.; Brady, Mark F.;
Bookman, Michael A.; Fleming, Gini F.; Huang, Helen; Homesley, Howard
D.; Fowler, Jeffrey M.; Greer, Benjamin E.; Boente, Matthew; Liang,
Sharon X.; Ye, Chenglin; Bais, Carlos; Randall, Leslie M.; Chan, John
K.; Ferriss, J. Stuart; Coleman, Robert L.; Aghajanian, Carol; Herzog,
Thomas J.; Disaia, Philip J.; Copeland, Larry J.; Mannel, Robert S.;
Birrer, Michael J.; Monk, Bradley J. |
Journal Of Clinical Oncology |
2019 |
| 20258 |
10.1200/jco.19.01154 |
Gefitinib Versus Gefitinib Plus Pemetrexed And
Carboplatin Chemotherapy In Egfr-Mutated Lung Cancer |
Noronha, Vanita; Patil, Vijay Maruti; Joshi, Amit;
Menon, Nandini; Chougule, Anuradha; Mahajan, Abhishek; Janu, Amit;
Purandare, Nilendu; Kumar, Rajiv; More, Sucheta; Goud, Supriya; Kadam,
Nandkumar; Daware, Nilesh; Bhattacharjee, Atanu; Shah, Srushti; Yadav,
Akanksha; Trivedi, Vaishakhi; Behel, Vichitra; Dutt, Amit; Banavali,
Shripad Dinanath; Prabhash, Kumar |
Journal Of Clinical Oncology |
2020 |
| 20261 |
10.1200/jco.19.01304 |
Neoadjuvant Talazoparib For Patients With Operable
Breast Cancer With A Germline Brca Pathogenic Variant |
Litton, Jennifer K.; Scoggins, Marion E.; Hess, Kenneth
R.; Adrada, Beatriz E.; Murthy, Rashmi K.; Damodaran, Senthil; Desnyder,
Sarah M.; Brewster, Abenaa M.; Barcenas, Carlos H.; Valero, Vicente;
Whitman, Gary J.; Schwartz-Gomez, Jill; Mittendorf, Elizabeth A.;
Thompson, Alastair M.; Helgason, Thorunn; Ibrahim, Nuhad; Piwnica-Worms,
Helen; Moulder, Stacy L.; Arun, Banu K. |
Journal Of Clinical Oncology |
2020 |
| 20263 |
10.1200/jco.19.01455 |
Nsabp B-47/Nrg Oncology Phase Iii Randomized Trial
Comparing Adjuvant Chemotherapy With Or Without Trastuzumab In High-Risk
Invasive Breast Cancer Negative For Her2 By Fish And With Ihc 1+ Or
2+ |
Fehrenbacher, Louis; Cecchini, Reena S.; Geyer Jr,
Charles E.; Rastogi, Priya; Costantino, Joseph P.; Atkins, James N.;
Crown, John P.; Polikoff, Jonathan; Boileau, Jean-Francois; Provencher,
Louise; Stokoe, Christopher; Moore, Timothy D.; Robidoux, Andre; Flynn,
Patrick J.; Borges, Virginia F.; Albain, Kathy S.; Swain, Sandra M.;
Paik, Soonmyung; Mamounas, Eleftherios P.; Wolmark, Norman |
Journal Of Clinical Oncology |
2020 |
| 20266 |
10.1200/jco.19.01488 |
Gefitinib Alone Versus Gefitinib Plus Chemotherapy For
Non<U+2013>Small-Cell Lung Cancer With Mutated Epidermal Growth
Factor Receptor: Nej009 Study |
Hosomi, Yukio; Morita, Satoshi; Sugawara, Shunichi;
Kato, Terufumi; Fukuhara, Tatsuro; Gemma, Akihiko; Takahashi, Kazuhisa;
Fujita, Yuka; Harada, Toshiyuki; Minato, Koichi; Takamura, Kei;
Hagiwara, Koichi; Kobayashi, Kunihiko; Nukiwa, Toshihiro; Inoue,
Akira |
Journal Of Clinical Oncology |
2020 |
| 20271 |
10.1200/jco.19.02059 |
Randomized Phase Ii Trial Of Nivolumab Versus Nivolumab
And Ipilimumab For Recurrent Or Persistent Ovarian Cancer: An Nrg
Oncology Study |
Zamarin, Dmitriy; Burger, Robert A.; Sill, Michael W.;
Powell, Daniel J.; Lankes, Heather A.; Feldman, Michael D.; Zivanovic,
Oliver; Gunderson, Camille; Ko, Emily; Mathews, Cara; Sharma, Sudarshan;
Hagemann, Andrea R.; Khleif, Samir; Aghajanian, Carol |
Journal Of Clinical Oncology |
2020 |
| 20275 |
10.1200/jco.19.02318 |
Antitumor Activity And Safety Of Trastuzumab Deruxtecan
In Patients With Her2-Low<U+2013>Expressing Advanced Breast
Cancer: Results From A Phase Ib Study |
Modi, Shanu; Park, Haeseong; Murthy, Rashmi K.; Iwata,
Hiroji; Tamura, Kenji; Tsurutani, Junji; Moreno-Aspitia, Alvaro; Doi,
Toshihiko; Sagara, Yasuaki; Redfern, Charles; Krop, Ian E.; Lee, Caleb;
Fujisaki, Yoshihiko; Sugihara, Masahiro; Zhang, Lin; Shahidi, Javad;
Takahashi, Shunji |
Journal Of Clinical Oncology |
2020 |
| 20276 |
10.1200/jco.19.02551 |
State-Of-The-Art Strategies For Targeting Ret-Dependent
Cancers |
Subbiah, Vivek; Yang, Dong; Velcheti, Vamsidhar;
Drilon, Alexander; Meric-Bernstam, Funda |
Journal Of Clinical Oncology |
2020 |
| 20278 |
10.1200/jco.19.02727 |
Pd-1 Blockade In Anaplastic Thyroid Carcinoma |
Capdevila, Jaume; Wirth, Lori J.; Ernst, Thomas; Ponce
Aix, Santiago; Lin, Chia-Chi; Ramlau, Rodryg; Butler, Marcus O.; Delord,
Jean-Pierre; Gelderblom, Hans; Ascierto, Paolo A.; Fasolo, Angelica;
Fuhrer, Dagmar, 0000-0003-0357-4192; Hutter-Kronke, Marie Luise; Forde,
Patrick M.; Wrona, Anna; Santoro, Armando; Sadow, Peter M.; Szpakowski,
Sebastian; Wu, Hongqian; Bostel, Geraldine; Faris, Jason; Cameron,
Scott; Varga, Andreea; Taylor, Matthew |
Journal Of Clinical Oncology |
2020 |
| 20279 |
10.1200/jco.19.02745 |
Olaparib Versus Nonplatinum Chemotherapy In Patients
With Platinum-Sensitive Relapsed Ovarian Cancer And A Germline Brca1/2
Mutation (Solo3): A Randomized Phase Iii Trial |
Penson, Richard T.; Valencia, Ricardo Villalobos;
Cibula, David; Colombo, Nicoletta; Leath, Charles A.;
Bidzi<U+0144>ski, Mariusz; Kim, Jae-Weon; Nam, Joo Hyun; Madry,
Radoslaw; Hernandez, Carlos; Mora, Paulo A.R.; Ryu, Sang Young;
Milenkova, Tsveta; Lowe, Elizabeth S.; Barker, Laura; Scambia,
Giovanni |
Journal Of Clinical Oncology |
2020 |
| 20287 |
10.1200/jco.20.00147 |
Neratinib Plus Capecitabine Versus Lapatinib Plus
Capecitabine In Her2-Positive Metastatic Breast Cancer Previously
Treated With <U+2265> 2 Her2-Directed Regimens: Phase Iii Nala
Trial |
Saura, Cristina; Oliveira, Mafalda; Feng, Yin-Hsun;
Dai, Ming-Shen; Chen, Shang-Wen; Hurvitz, Sara A.; Kim, Sung-Bae; Moy,
Beverly; Delaloge, Suzette; Gradishar, William; Masuda, Norikazu;
Palacova, Marketa; Trudeau, Maureen E.; Mattson, Johanna; Yap, Yoon Sim;
Hou, Ming-Feng; De Laurentiis, Michelino; Yeh, Yu-Min; Chang, Hong-Tai;
Yau, Thomas; Wildiers, Hans; Haley, Barbara; Fagnani, Daniele; Lu,
Yen-Shen; Crown, John; Lin, Johnson; Takahashi, Masato; Takano, Toshimi;
Yamaguchi, Miki; Fujii, Takaaki; Yao, Bin; Bebchuk, Judith; Keyvanjah,
Kiana; Bryce, Richard; Brufsky, Adam |
Journal Of Clinical Oncology |
2020 |
| 20289 |
10.1200/jco.20.00505 |
Brigatinib Versus Crizotinib In Advanced Alk
Inhibitor<U+2013>Naive Alk-Positive Non<U+2013>Small Cell
Lung Cancer: Second Interim Analysis Of The Phase Iii Alta-1L Trial |
Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang,
James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Lee, Ki Hyeong;
Delmonte, Angelo; Garcia Campelo, Maria Rosario; Kim, Dong-Wan;
Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira,
Alexander; Gettinger, Scott N.; Tiseo, Marcello; Lin, Huamao M.; Gupta,
Neeraj; Hanley, Michael J.; Ni, Quanhong; Zhang, Pingkuan; Popat,
Sanjay |
Journal Of Clinical Oncology |
2020 |
| 20292 |
10.1200/jco.20.00775 |
Intracranial Efficacy And Survival With Tucatinib Plus
Trastuzumab And Capecitabine For Previously Treated Her2-Positive Breast
Cancer With Brain Metastases In The Her2Climb Trial |
|
Journal Of Clinical Oncology |
2020 |
| 20300 |
10.1200/jco.20.01888 |
Randomized Phase Iii Keynote-181 Study Of Pembrolizumab
Versus Chemotherapy In Advanced Esophageal Cancer |
Kojima, Takashi, 0000-0002-2554-8334; Shah, Manish A.,
0000-0002-6913-9655; Muro, Kei; Francois, Eric; Adenis, Antoine; Hsu,
Chih-Hung; Doi, Toshihiko, 0000-0003-2042-6829; Moriwaki, Toshikazu,
0000-0001-7702-122X; Kim, Sung-Bae, 0000-0001-5588-8332; Lee, Se-Hoon,
0000-0002-9219-3350; Bennouna, Jaafar; Kato, Ken, 0000-0002-1733-5072;
Shen, Lin, 0000-0002-8798-4756; Enzinger, Peter; Qin, Shu-Kui,
0000-0003-2289-1521; Ferreira, Paula; Chen, Jia; Girotto, Gustavo,
0000-0002-4098-1320; De La Fouchardiere, Christelle,
0000-0003-2291-5693; Senellart, Helene; Al-Rajabi, Raed; Lordick,
Florian; Wang, Ruixue; Suryawanshi, Shailaja; Bhagia, Pooja; Kang, S.
Peter; Metges, Jean-Philippe |
Journal Of Clinical Oncology |
2020 |
| 20302 |
10.1200/jco.20.02151 |
Tbcrc 048: Phase Ii Study Of Olaparib For Metastatic
Breast Cancer And Mutations In Homologous Recombination-Related
Genes |
|
Journal Of Clinical Oncology |
2020 |
| 20307 |
10.1200/jco.2017.76.6212 |
Checkmate-032 Study: Efficacy And Safety Of Nivolumab
And Nivolumab Plus Ipilimumab In Patients With Metastatic
Esophagogastric Cancer |
Janjigian, Yelena Y.; Bendell, Johanna; Calvo,
Emiliano; Kim, Joseph W.; Ascierto, Paolo A.; Sharma, Padmanee; Ott,
Patrick A.; Peltola, Katriina; Jaeger, Dirk; Evans, Jeffry; De Braud,
Filippo; Chau, Ian; Harbison, Christopher T.; Dorange, Cecile; Tschaika,
Marina; Le, Dung T. |
Journal Of Clinical Oncology |
2018 |
| 20310 |
10.1200/jco.2017.77.4794 |
Final Overall Survival Analysis From A Study Comparing
First-Line Crizotinib Versus Chemotherapy In Alk-Mutation-Positive
Non<U+2013>Small-Cell Lung Cancer |
Solomon, Benjamin J.; Kim, Dong-Wan; Wu, Yi-Long;
Nakagawa, Kazuhiko; Mekhail, Tarek; Felip, Enriqueta; Cappuzzo,
Federico; Paolini, Jolanda; Usari, Tiziana; Tang, Yiyun; Wilner, Keith
D.; Blackhall, Fiona; Mok, Tony S. |
Journal Of Clinical Oncology |
2018 |
| 20313 |
10.1200/jco.2018.77.7326 |
Phase Ib/Ii Study Of Capmatinib (Inc280) Plus Gefitinib
After Failure Of Epidermal Growth Factor Receptor (Egfr) Inhibitor
Therapy In Patients With Egfr-Mutated, Met
Factor<U+2013>Dysregulated Non<U+2013>Small-Cell Lung
Cancer |
Wu, Yi-Long; Zhang, Li; Kim, Dong-Wan; Liu, Xiaoqing;
Lee, Dae Ho; Yang, James Chih-Hsin; Ahn, Myung-Ju; Vansteenkiste, Johan
F.; Su, Wu-Chou; Felip, Enriqueta; Chia, Vincent; Glaser, Sabine;
Pultar, Philippe; Zhao, Sylvia; Peng, Bin; Akimov, Mikhail; Tan, Daniel
S.W. |
Journal Of Clinical Oncology |
2018 |
| 20314 |
10.1200/jco.2018.77.7672 |
Randomized, Double-Blind, Phase Ii Study Of
Temozolomide In Combination With Either Veliparib Or Placebo In Patients
With Relapsed-Sensitive Or Refractory Small-Cell Lung Cancer |
Pietanza, M. Catherine; Waqar, Saiama N.; Krug, Lee M.;
Dowlati, Afshin; Hann, Christine L.; Chiappori, Alberto; Owonikoko,
Taofeek K.; Woo, Kaitlin M.; Cardnell, Robert J.; Fujimoto, Junya; Long,
Lihong; Diao, Lixia; Wang, Jing; Bensman, Yevgeniva; Hurtado, Brenda; De
Groot, Patricia; Sulman, Erik P.; Wistuba, Ignacio I.; Chen, Alice;
Fleisher, Martin; Heymach, John V.; Kris, Mark G.; Rudin, Charles M.;
Byers, Lauren Averett |
Journal Of Clinical Oncology |
2018 |
| 20316 |
10.1200/jco.2018.77.9363 |
Cns Efficacy Of Osimertinib In Patients With
T790M-Positive Advanced Non<U+2013>Small-Cell Lung Cancer: Data
From A Randomized Phase Iii Trial (Aura3) |
Wu, Yi-Long; Ahn, Myung-Ju; Garassino, Marina Chiara;
Han, Ji-Youn; Katakami, Nobuyuki; Kim, Hye Ryun; Hodge, Rachel; Kaur,
Paramjit; Brown, Andrew P.; Ghiorghiu, Dana; Papadimitrakopoulou,
Vassiliki A.; Mok, Tony S.K. |
Journal Of Clinical Oncology |
2018 |
| 20317 |
10.1200/jco.2018.77.9777 |
Ado-Trastuzumab Emtansine For Patients With Her2-Mutant
Lung Cancers: Results From A Phase Ii Basket Trial |
Li, Bob T.; Shen, Ronglai; Buonocore, Darren; Olah,
Zachary T.; Ni, Ai; Ginsberg, Michelle S.; Ulaner, Gary A.; Offin,
Michael; Feldman, Daniel; Hembrough, Todd; Cecchi, Fabiola; Schwartz,
Sarit; Pavlakis, Nick; Clarke, Stephen; Won, Helen H.; Brzostowski,
Edyta B.; Riely, Gregory J.; Solit, David B.; Hyman, David M.; Drilon,
Alexander; Rudin, Charles M.; Berger, Michael F.; Baselga, Jose;
Scaltriti, Maurizio; Arcila, Maria E.; Kris, Mark G. |
Journal Of Clinical Oncology |
2018 |
| 20318 |
10.1200/jco.2018.78.3118 |
Cns Response To Osimertinib Versus Standard Epidermal
Growth Factor Receptor Tyrosine Kinase Inhibitors In Patients With
Untreated Egfr-Mutated Advanced Non<U+2013>Small-Cell Lung
Cancer |
Reungwetwattana, Thanyanan; Nakagawa, Kazuhiko; Cho,
Byoung Chul; Cobo, Manuel; Cho, Eun Kyung; Bertolini, Alessandro;
Bohnet, Sabine; Zhou, Caicun; Lee, Ki Hyeong; Nogami, Naoyuki; Okamoto,
Isamu; Leighl, Natasha; Hodge, Rachel; Mckeown, Astrid; Brown, Andrew
P.; Rukazenkov, Yuri; Ramalingam, Suresh S.; Vansteenkiste, Johan |
Journal Of Clinical Oncology |
2018 |
| 20323 |
10.1200/jco.2019.37.15_suppl.1000 |
Sophia Primary Analysis: A Phase 3 (P3) Study Of
Margetuximab (M) + Chemotherapy (C) Versus Trastuzumab (T) + C In
Patients (Pts) With Her2+ Metastatic (Met) Breast Cancer (Mbc) After
Prior Anti-Her2 Therapies (Tx). |
Rugo, Hope S.; Im, Seock-Ah; Wright, Gail Lynn Shaw;
Escriva-De-Romani, Santiago; Delaurentiis, Michelino; Cortes, Javier;
Bahadur, Shakeela Wazeen; Haley, Barbara B.; Oyola, Raul H.; Riseberg,
David A.; Musolino, Antonino; Cardoso, Fatima; Curigliano, Giuseppe;
Kaufman, Peter A.; Pegram, Mark D.; Edlich, Sutton; Hong, Sam; Rock,
Edwin P.; Gradishar, William John |
Journal Of Clinical Oncology |
2019 |
| 20324 |
10.1200/jco.2019.37.15_suppl.1002 |
Neratinib + Capecitabine Versus Lapatinib +
Capecitabine In Patients With Her2+ Metastatic Breast Cancer Previously
Treated With <U+2265> 2 Her2-Directed Regimens: Findings From The
Multinational, Randomized, Phase Iii Nala Trial. |
Saura, Cristina; Oliveira, Mafalda; Feng, Yin-Hsun;
Dai, Ming-Shen; Hurvitz, Sara A.; Kim, Sung-Bae; Moy, Beverly; Delaloge,
Suzette; Gradishar, William John; Masuda, Norikazu; Palacova, Marketa;
Trudeau, Maureen E.; Mattson, Johanna; Yap, Yoon Sim; Bryce, Richard;
Yao, Bin; Bebchuk, Judith D.; Keyvanjah, Kiana; Brufsky, Adam |
Journal Of Clinical Oncology |
2019 |
| 20332 |
10.1200/jco.2019.37.15_suppl.9004 |
|
Wolf, Juergen; Seto, Takashi; Han, Ji-Youn; Reguart,
Noemi; Garon, Edward B.; Groen, Harry J.M.; Tan, Daniel Shao-Weng; Hida,
Toyoaki; De Jonge, Maja J.; Orlov, Sergey V.; Smit, Egbert F.; Souquet,
Pierre Jean; Vansteenkiste, Johan F.; Giovannini, Monica; Le Mouhaer,
Sylvie; Robeva, Anna; Waldron-Lynch, Maeve; Heist, Rebecca Suk |
Journal Of Clinical Oncology |
2019 |
| 20333 |
10.1200/jco.2019.37.15_suppl.9008 |
Clinical Activity And Tolerability Of Blu-667, A Highly
Potent And Selective Ret Inhibitor, In Patients (Pts) With Advanced
Ret-Fusion+ Non-Small Cell Lung Cancer (Nsclc). |
Gainor, Justin F.; Lee, Dae Ho; Curigliano, Giuseppe;
Doebele, Robert Charles; Kim, Dong-Wan; Baik, Christina S; Tan, Daniel
Shao-Weng; Lopes, Gilberto; Gadgeel, Shirish M.; Cassier, Philippe
Alexandre; Taylor, Matthew H.; Liu, Stephen V.; Besse, Benjamin; Thomas,
Michael; Zhu, Viola Weijia; Zhang, Hui; Clifford, Corinne; Palmer,
Michael; Turner, Christopher D.; Subbiah, Vivek |
Journal Of Clinical Oncology |
2019 |
| 20334 |
10.1200/jco.2019.37.18_suppl.lba4007 |
Pembrolizumab With Or Without Chemotherapy Versus
Chemotherapy For Advanced Gastric Or Gastroesophageal Junction (G/Gej)
Adenocarcinoma: The Phase Iii Keynote-062 Study. |
Tabernero, Josep; Van Cutsem, Eric; Bang, Yung-Jue;
Fuchs, Charles S.; Wyrwicz, Lucjan; Lee, Keun Wook; Kudaba, Iveta;
Garrido, Marcelo; Chung, Hyun Cheol; Castro Salguero, Hugo Raul;
Mansoor, Wasat; Braghiroli, Maria Ignez Freitas Melro; Goekkurt, Eray;
Chao, Joseph; Wainberg, Zev A.; Kher, Uma; Shah, Sukrut; Kang, Soonmo
Peter; Shitara, Kohei |
Journal Of Clinical Oncology |
2019 |
| 20337 |
10.1200/jco.2019.37.4_suppl.2 |
Pembrolizumab Versus Chemotherapy As Second-Line
Therapy For Advanced Esophageal Cancer: Phase Iii Keynote-181
Study. |
Kojima, Takashi; Muro, Kei; Francois, Eric; Hsu,
Chih-Hung; Moriwaki, Toshikazu; Kim, Sung-Bae; Lee, Se-Hoon; Bennouna,
Jaafar; Kato, Ken; Lin, Shen; Qin, Shi-Qui; Ferreira, Paula; Doi,
Toshihiko; Adenis, Antoine; Enzinger, Peter C.; Shah, Manish A.; Wang,
Ruixue; Bhagia, Pooja; Kang, S. Peter; Metges, Jean-Philippe |
Journal Of Clinical Oncology |
2019 |
| 20341 |
10.1200/jco.2020.38.15_suppl.1000 |
Keynote-355: Randomized, Double-Blind, Phase Iii Study
Of Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy For
Previously Untreated Locally Recurrent Inoperable Or Metastatic
Triple-Negative Breast Cancer. |
Cortes, Javier; Cescon, David W.; Rugo, Hope S.;
Nowecki, Zbigniew; Im, Seock-Ah; Yusof, Mastura Md; Gallardo, Carlos;
Lipatov, Oleg; Barrios, Carlos Henrique; Holgado, Esther; Iwata, Hiroji;
Masuda, Norikazu; Torregroza Otero, Marco; Gokmen, Erhan; Loi, Sherene;
Guo, Zifang; Zhao, Jing; Aktan, Gursel; Karantza, Vassiliki; Schmid,
Peter |
Journal Of Clinical Oncology |
2020 |
| 20349 |
10.1200/jco.2020.38.15_suppl.9504 |
Trastuzumab Deruxtecan (T-Dxd; Ds-8201) In Patients
With Her2-Mutated Metastatic Non-Small Cell Lung Cancer (Nsclc): Interim
Results Of Destiny-Lung01. |
Smit, Egbert F.; Nakagawa, Kazuhiko; Nagasaka, Misako;
Felip, Enriqueta; Goto, Yasushi; Li, Bob T.; Pacheco, Jose Maria;
Murakami, Haruyasu; Barlesi, Fabrice; Saltos, Andreas Nicholas; Perol,
Maurice; Udagawa, Hibiki; Saxena, Kapil; Shiga, Ryota; Guevara,
Ferdinand M.; Acharyya, Suddhasatta; Shahidi, Javad; Planchard, David;
Janne, Pasi A. |
Journal Of Clinical Oncology |
2020 |
| 20434 |
10.1248/cpb.c18-00744 |
The Latest Research And Development Into The
Antibody<U+2013>Drug Conjugate, [Fam-] Trastuzumab Deruxtecan
(Ds-8201A), For Her2 Cancer Therapy |
Nakada, Takashi; Sugihara, Kiyoshi; Jikoh, Takahiro;
Abe, Yuki; Agatsuma, Toshinori |
Chemical And Pharmaceutical Bulletin |
2019 |
| 20621 |
10.15252/emmm.201809172 |
A Rad 51 Assay Feasible In Routine Tumor Samples Calls
Parp Inhibitor Response Beyond Brca Mutation |
|
Embo Molecular Medicine |
2018 |
| 20812 |
10.2217/fon-2018-0557 |
A Phase Ii Study Of The Safety And Efficacy Of
Lenvatinib In Patients With Advanced Thyroid Cancer |
Takahashi, Shunji; Kiyota, Naomi; Yamazaki, Tomoko;
Chayahara, Naoko; Nakano, Kenji; Inagaki, Lina; Toda, Kazuhisa; Enokida,
Tomohiro; Minami, Hironobu; Imamura, Yoshinori; Fukuda, Naoki; Sasaki,
Tatsuya; Suzuki, Takuya; Ikezawa, Hiroki; Dutcus, Corina E; Tahara,
Makoto |
Future Oncology |
2019 |
| 21179 |
10.3390/ijms20051115 |
Her2 Directed Antibody-Drug-Conjugates Beyond T-Dm1 In
Breast Cancer |
Rinnerthaler, Gabriel; Gampenrieder, Simon; Greil,
Richard, 0000-0002-4462-3694 |
International Journal Of Molecular Sciences |
2019 |